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resumo 
 
 
Os produtos naturais são ainda hoje a maior fonte de descoberta de novas 
moléculas. Os lantipéptidos são um grupo de produtos naturais que pertencem 
à família de péptidos sintetizados pelos ribossomas e sujeitos a modificações 
pós-traducionais (RiPPs). Estas modificações incluem a desidratação de Ser e 
Thr e a ciclização entre estes aminoácidos desidratados e a Cys, dando 
origem aos característicos anéis de lantionina (Lan) e/ou metilantionina 
(MeLan). Estas reações são catalisadas por diferentes tipos de enzimas (LanB, 
LanM, LanKC e LanL), que constituem a base da classificação destes 
péptidos. Estas proteínas são codificadas em várias espécies de bactérias e 
possuem homólogos tanto no domínio Eukarya como no domínio Archaea.  
Os objectivos deste trabalho foram: i) identificar os clusters de lantipéptidos 
presentes no genomas de Archaea, recorrendo a bases de dados públicas, ii) 
caracterizar os clusters identificados e, por último, iii) identificar os padrões de 
desidratação e ciclização dos lantipéptidos encontrados em Haloferax 
mediterranei ATCC 33500.  
Em Archaea foram detectados apenas genes lanM, que estão confinados aos 
genomas de organismos pertencentes à classe Halobacteria. Uma procura 
“manual” in silico na região genómica de cada lanM permitiu identificar a 
presença de vários genes lanA. A análise da sequência dos lantipéptidos 
codificados por estes lanAs não identificou motivos conservados, mas permitiu 
a sua divisão em grupos diferentes. Os clusters que contêm estes genes 
também codificam proteínas de função desconhecida e transportadores ABC. 
Nenhum destes transportadores é do tipo SunT (LanT) que estão normalmente 
associados ao processamento de lantipéptidos modificados por LanMs. 
Haloferax mediterranei ATCC 33500 foi selecionado para uma caracterização 
mais aprofundada uma vez que possui três genes lanM: um no cromossoma 
(medM1) e dois num plasmídeo (medM2 e medM3). Foram construídos três 
vetores que permitiram a co-expressão dos genes medM e His6-medA em 
Escherichia coli. Após produção, purificação por IMAC e análise por MALDI-
TOF, verificou-se que nenhum dos péptidos foi desidratado. Desta forma, as 
enzimas MedM não parecem estar funcionais no citoplasma de E. coli, 
necessitando provavelmente de elevadas concentrações de sal para exercer 
as suas funções. Desta forma, utilizou-se um outro hospedeiro para expressão 
heteróloga: a Archaea Haloferax volcanii H1424. Para tal, foram construídos 
novos vectores de co-expressão baseados no plasmídeo pTA1392, contendo 
dois promotores (e não apenas um como na versão original). Após 
transformação de H. volcanii, os péptidos foram produzidos e purificados por 
IMAC. A análise por MALDI-TOF, não revelou a presença de nenhum dos His6-
MedA. Consequentemente, será necessário optimizar os protocolos de 
produção e/ou purificação destes péptidos de H. volcanii. O sucesso desta 
optimização permitirá provar a funcionalidade das enzimas MedM e 
estabelecer um sistema de expressão de natureza halófita que poderá ser útil 
para o estudo de outros clusters biosintéticos de Archaea. 
Concluindo, organismos do domínio Archaea, em particular Halobacteria, 
codificam enzimas envolvidas na biossíntese de lantipéptidos homólogas às 
encontradas em bactérias. Os lantipéptidos de bactérias normalmente são 
bacteriocinas. Se os lantipéptidos de Archaea possuírem atividade contra 
outras Archaea (archaeocinas), poderão ser uma ferramenta valiosa para o 
desenvolvimento de novos marcadores seletivos. Isto permitirá melhorar as 
ferramentas existentes para manipulação genética de Archaea. 
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abstract 
 
Natural products are to this day the major source of novel molecules. 
Lanthipeptides are a group of natural products belonging to the family of 
ribosomally synthesized and post-translationally modified peptides (RiPPs). 
Their modifications include the dehydration of Ser and Thr residues 
immediately followed by a cyclization reaction between the dehydrated amino 
acids and Cys to form their characteristic lanthionine (Lan) and/or 
methyllanthionine (MeLan) rings. These reactions are catalyzed by different 
types of enzymes (LanB, LanM, LanKC and LanL), that define the classification 
of lanthipeptides. These proteins are encoded in a wide range of bacterial 
species and have homologues also in Eukarya and Archaea.  
The objectives of this work were: i) identify lanthipeptide clusters in the publicly 
available archaeal genomes, ii) characterize the archaeal lanthipeptide gene 
clusters and iii) identify the dehydration and cyclization pattern of putative 
lanthipeptides from Haloferax mediterranei ATCC 33500. 
Archaea encodes exclusively LanM enzymes (21 lanM genes) and they are 
confined to organisms of the class Halobacteria. Manual search of the genetic 
neighborhood of each lanM allowed to identify several lanA genes. The putative 
lanthipeptides encoded by these lanAs do not share conserved motifs but, 
based on their sequences, they can be divided into groups. Their gene clusters 
also encode proteins of unknown function and ABC transporters. None of these 
transporters are of the SunT-type (LanT) that is classically involved in the 
processing of LanM-modified lanthipeptides. Haloferax mediterranei ATCC 
33500 was selected for further characterization because it has three lanM 
genes: one on the chromosome (medM1) and two on a plasmid (medM2 e 
medM3). Three expression vectors were constructed to allow the co-expression 
of medM and His6-medA genes in Escherichia coli. After production, purification 
by IMAC and MALDI-ToF analysis, it was found that none of the peptides were 
dehydrated. This indicates that MedM enzymes are not functional in E. coli 
cytoplasm. Most probably, their functionality is dependent on high 
concentrations of salt. Therefore, another heterologous expression host was 
used: the archaeon Haloferax volcanii H1424. To this purpose, new co-
expression vectors were constructed based on the pTA1392 plasmid and 
containing two promoters, instead of the original one. After transformation of H. 
volcanii, peptide production, IMAC purification and MALDI-ToF analysis, none 
of the His6-MedA peptides were identified. Thus, in the future, optimization of 
the production procedures and/or purification of these peptides from H. volcanii 
will be needed. This will prove the functionality of MedM enzymes and will 
establish a system with halofilic nature that can be useful for the investigation 
of other biosynthetic clusters from Archaea. 
In conclusion, Archaea, in particular Halobacteria, encode lanthipeptide 
enzymes that are homologous to those found in Bacteria. In Bacteria, these 
peptides commonly have antibacterial activity. If archaeal lanthipeptides are 
archaeocins, these peptides will be a valuable tool for the development of novel 
selective markers for Archaea. This will be highly relevant to improve the tool-
box for the genetic manipulation of Archaea. 
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1.1 Natural products and RiPPs 
Molecular evolution on Earth is responsible for the extraordinary library of chemical structures 
present in millions of species and impossible to reproduce by human hand either in number, 
diversity and function. Besides their natural role in complex biological systems, these molecules 
often have a lot to offer to the scientific and medical communities. In fact, many of the major 
therapeutic drugs commercially available from the past 50 years are natural products or based on 
their chemical skeleton1. The classical ways of obtaining natural products either by extraction or 
organic synthesis are now being complemented by the massive amounts of genetic information 
being amassed from all domains of life and the development of systems that allow the 
manipulation of biosynthetic pathways and the discovery of novel molecules 2.  
Ribossomally synthesized and post-translationally modified peptides (RiPPs) are a large class of 
structurally diverse natural products that is gaining considerable attention for their biological 
activities and characteristic biosynthetic pathways. Capable of a similar degree of chemical 
diversity thought possible only when referring to nonribosomal peptides, through the activity of 
the large, multimodular nonribosomal peptide synthetases (NRPSs), RiPPs rely instead on 
extensive post translational modifications (PTMs) of a ribosomally synthesized precursor peptide3. 
These modifications are responsible for the variety of chemical structures and consequently the 
wide range of activities, from antibiotics4 and antivirals5 to allelopathics6. 
RiPPs are divided into different subfamilies based on their characteristic biosynthetic machinery 
and structural features. Despite subfamily, RiPPs biosynthesis starts with the ribosomal 
translation of the precursor peptide. This precursor peptide usually contains an N-terminal leader 
sequence and a C-terminal core region that will be subject to the post translational modifications. 
The biosynthetic machinery then recognizes the leader sequence (sometimes a signal sequence is 
also present in the C-terminal region) and catalyzes the various amount of PTMs. Thereafter, the 
leader sequence of the peptide is cleaved by peptidases to yield the mature product. Removal of 
the leader sequence usually translates into an active peptide (Figure 1). Lanthipeptides are a RiPP 
subfamily which are gaining considerable interest. 
 
 
Figure 1 RiPPs biosynthesis schematic from Repka et al 2017 7. 
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1.2 Lanthipeptides 
Lanthionine containing peptides, or lanthipeptides, are a class of molecules that contain in their 
structure lanthionine (Lan) and methyllanthionine (MeLan) residues. They are the largest group of 
RiPPs based on the frequency of their biosynthetic gene clusters in currently available genomes8. 
These residues are modified in a characteristic two-step mechanism. First the serine and 
threonine amino acids present in the precursor peptide are dehydrated to dehydroalanine (Dha) 
and dehydrobutyrine (Dhb), respectively. Then follows cyclization where the thioether crosslinks 
are formed via a Michael-type like reaction done by a nucleophilic attack of Cysteine to the 
dehydro amino acids. The formed rings are what give these peptides their stable conformational 
structure and are also essential for their biological activities. The present classification system 
allows for four different classes of lanthipeptides depending on the biosynthetic enzymes that 
catalyze these reactions9. A recent attempt for a common nomenclature determined that the 
biosynthetic genes for lanthipeptides attributed the generic symbol lan, with a more specific 
designation for each lanthipeptide molecule9. For example the gene coding for the precursor 
peptide of nisin is termed nisA and for its biosynthetic enzymes genes nisB and nisC. 
Dating back to 1928, Nisin, produced by Lactococcus lactis, was the first reported lanthipeptide. 
Given their complex and unusual composition of amino acids, lanthipeptides were thought to be 
the product of a non-ribosomal mechanism. It wasn’t until the 1980’s that the ribosomal origin of 
this class of peptides was verified in the laboratory, with the identification of the gene for the 
precursor peptide of epidermin10. Genes encoding homologues of lanthipeptide enzymes seem to 
be present in all domains of life. For instance, a LanC like protein was attributed the role of a 
transcription suppressor when overexpressed in human tumors11 and that of a kinase regulator in 
human liver cells 12, but peptide isolation is so far restricted to bacteria.  
 
1.2.1 Lantibiotics – unique mode of action 
Nisin brought special attention to this class of RiPPs due to its long standing action as an 
antimicrobial in the food industry without substantial incidence of microbial resistance13. The 
lanthipeptides with antimicrobial activity are called lantibiotics. Isolated lantibiotics possess 
potent activity against many of the today clinically relevant strains of both the Gram-positive and 
some of the Gram-negative bacteria. Many lantibiotics display highly specific activity against a 
rather limited spectrum of sensitive strains and a lower activity against a broader range of 
organisms.4 This high activity and low incidence of resistance can be explained by the dual mode 
of action of these peptides. Molecules like nisin, subtilin and epidermin have the ability to both 
affect cell wall biosynthesis and disrupt the cytoplasmatic membrane integrity by pore 
formation14. The formed pores allow the efflux of ions and small molecules and the inevitable 
dissipation of the membrane potential. The same authors that demonstrated the hydrophilic 
conformation of nisin in water postulated that the molecule may have a different behavior in its 
target site, the phospholipid membrane. In a conformational study using membrane mimetics 
they concluded that the molecule adopts an amphipathic conformation that enables the peptides 
to reach into the bacterial membrane, inducing enough perturbations to the phospholipids that 
allow their eventual assembly into a pore15. It is now known that nisin uses lipid II, the central 
building block of the membrane wall, as a docking molecule for pore formation. The two N-
terminal rings of nisin form a stable complex, called the pyrophosphate cage that envelops the 
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bactoprenol moieties of the lipid II intermediate of cell wall biosynthesis. This binding pocket is 
stabilized by hydrogen bonds involving several residues of nisin. After binding to lipid II, the C-
terminus of nisin is able to insert into the membrane, oligomerize and form a pore that contains 
eight nisin molecules and four lipid II molecules16. Pore formation might also be the reason why 
nisin is capable of inhibiting the growth of bacterial spores. Although this might not be true to all 
lantibiotics, the conservation of a nisin like structure possibly endows these molecules with a 
similar mode of action.   
 
1.2.2 The different classes of lanthipeptides 
The most recent and broadly used classification system for this class of RiPPs is based on the 
catalytic machinery responsible for the dehydration and cyclization reactions9 (Figure 2). Presently 
this family of RiPPs is divided in four classes, discussed with further detail below. 
 
 
Figure 2 A) The two step mechanism of lanthipeptide ring formation B) The four classes of enzymatic machinery 
responsible for the PTMs. Schematic from Zhang et al, 2015 17. 
 
1.2.2.1 Class I Lanthipeptides  
The prototypical lanthipeptide nisin belongs to class I lanthipeptides. The biosynthesis of nisin is 
encoded by a transcriptional operon of 11 genes. This operon encodes the precursor peptide, 
NisA and several others proteins responsible for the characteristic lanthipeptide PTMs, precursor 
peptide cleavage, transport and also immunity from the mature peptide. The dehydratase NisB 
catalyzes the dehydration of serine and threonine in the core peptide. The cyclase NisC catalyzes 
the attack of cysteine to the dehydrated residues generating the five lanthionine rings of nisin. 
NisP, a protease, removes the leader sequence from the precursor peptide, allowing for the final, 
mature, bioactive product. To avoid self-destruction, genes for immunity or self-preservation 
proteins, nisI and nisFEG, are also present. NisI is a lipoprotein that sequesters nisin. It was shown 
to act bound to the cell membrane but it could also be excreted to the medium as a potential 
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enhancer18. The ABC transporter homologous system, NisFEG, seems to work by expelling nisin 
molecules into the environment in a NisI independent fashion19. As they serve as a basis for 
lanthipeptide classification, an exploration of the mechanisms of the dehydration and cyclization 
will be further explored.  
Dehydration by LanBs. Although nisin being known since the 30’s, the knowledge of their 
ribosomally synthesized nature and the exact function of their biosynthetic enzymes came later 
on. Works like the one carried by Koponen et al (2002) made obvious the role of the genes nisB 
and nisC in these PTM20. The expression of a histidine tagged nisA in L. lactis mutants, revealed 
the dehydratase function of NisB and the cyclase one of NisC. Although in vivo activity studies 
were yielding exciting results, in vitro studies revealed a challenge limiting our understanding of 
these modifications. It wasn’t until 2013 that a peak at the reaction mechanics was possible. 
Glutamylation of serine and threonine residues in the precursor peptide was key for obtaining the 
dehydrated product (Figure 3). Mutational analysis revealed that the N-terminal domain of NisB 
was responsible for creating the glutamylated precursor intermediate, and posterior elimination 
of glutamate was attributed to a C-terminal domain21. These two domains seem to possess unique 
structure and they share no similarity with other known protein families. The current mechanistic 
models state that LanBs use the readily available activated glutamate present in the cellular 
medium (glutamyl-tRNA) to catalyze the dehydration reaction. A co-evolution event seems to be 
at play also. Differences in tRNA, namely the acceptor stem sequence determine the recognition 
of the glutamyl-tRNA by the dehydratase. This means that heterologous expression systems might 
not work in every case as an appropriate tRNA must be present 22.  
 
 
Figure 3 Dehydration step catalyzed by LanBs. In light grey are the conserved NisB residues thought to be involved in 
the reaction. Illustration from Repka et al, 2017 7. 
 
Cyclization by LanCs. The second step of lanthionine formation is done by the attack of the 
cysteine thiol group to the dehydrated residues (Figure 4). This reaction can be recreated in the 
laboratory, as it seems to not need the enzymatic action of the cyclase in a basic solution. 
Interestingly, cyclization occurrence does not mean correct overall peptide structure. Chemical 
synthesis studies with nisin revealed that the reaction products were a mix of different structures 
and NisC was needed for the assembly of the correct ring topology with the possible reason being 
that the reaction rate of Dha+Cys is higher than DhB+Cys7 resulting is abnormal ring formation. 
Nevertheless, other studies involving the elimination of the lanC genes suggested that cyclization 
will not occur in the cell cytoplasm without the enzyme. NisC is a metalloenzyme and 
crystallography data suggested that a zinc ion is complexed with the residues Cys284, Cys330, and 
His331. Mutational studies also attributed relevance towards correct cyclization activity to the 
NisC residues His212 and Asp141 that is hydrogen-bonded to His212 in the crystal structure23. 
Conservation of these residues or chemically similar amino acids might be a good indication of 
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cyclase activity in putative novel enzymes identified in today’s available genomes. The proposed 
model for this metalloenzyme reaction mechanism presumes that the zinc ion is essential for the 
deprotonation of the thiol group of cysteine by lowering its pKa as is observed in other similar 
enzymes. The sulfur is then ready for the nucleophilic attack on the dehydrated residue, Dha or 
Dhb, β- carbon. LanC enzymes seem also to be essential for correct ring stereoisomery. The 
characteristic stereochemistry of the MeLan ring in nisin seems possible only by the aid of a 
nearby amino acid. Is not yet understood how LanC enzymes control cyclization and determine a 
specific structure to a lanthipeptide as a number of combinations are possible between cysteine 
and the dehydrated residues to form a myriad of ring structures. Two hypothesis are in order. 
One way to reduce the number of possible combinations is having less dehydrated residues per 
cysteine at the time of cyclization. This means that although they act as standalone enzymes, LanB 
and LanC coupled activity seems to be essential for the correct structure of a number of 
lanthipeptides. Cyclization of a readily available dehydrated amino acid, determines where the 
next dehydration will occur, as a lanthipeptide ring might prevent a dehydration reaction on a 
nearby serine or threonine residue. Another possibility is that the substrate sequence has an 
inherent preference for a determined ring topology limiting LanC cyclization range. It is also quite 
possible that a mix of this strategies is used for the production of the final lanthipeptide structure 
7.  
 
 
Figure 4 Proposed cyclization mechanism, using nisin ring formation and NisC activity as an example. His212 might 
supply the proton for final ring structure, represented as H-A. Image adapted from Repka et al, 20177. 
. 
1.2.2.2 Class II Lanthipeptides  
This class of peptides is characterized by the presence of bifunctional enzymes, LanMs, which are 
responsible for the dehydration and cyclization steps towards lanthinine ring formation. A LanC 
like domain in the C-terminal region of the protein was immediately identified as the cyclization 
domain. The N-terminal region responsible for the dehydration step, had no homology with any 
known lanthipeptide domains. That is explained by the fact that, unlike class I lanthipeptides, the 
dehydration reaction is accomplished through phosphorylation instead of glutamylation8.  
One subgroup of class II lanthipeptides is the two-component lantibiotics. These lanthipeptides 
display maximum activity when two different post-translationally modified peptides are used 
together. For most two-component lantibiotics, two different LanM enzymes carry out the 
dehydrations and cyclizations steps of the two different LanA substrates7. The exception is 
cytolysin, where only one LanM, CylM, is responsible for the PTMs. Cytolysin seems to lack 
antibiotic activity but instead acts as a virulence factor, lysing mammalian cells24. 
LanM N-terminal dehydration domain. A structural study of dehydratase domain of CylM, the 
first of its kind on LanMs, revealed that it resembles the catalytic core of eukaryotic lipid kinases, 
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despite the absence of clear sequence homology25. Compared with canonical lipid kinases the 
CylM dehydration domain is significantly larger and contains additional subdomains. These are 
the kinase-activation domain, the P-loop and the C-lobe that seem to play a role in the reaction 
mechanism. Once again, mutational studies shed light on the importance of several residues in 
the dehydration step (Figure 5). Asp252 and His254, located on the P-loop appear to be involved 
in the activation of adenosine triphosphate (ATP) for serine/threonine phosphorylation. Asp347 
and His349, located on the C-lobe accept a proton from serine/threonine for phosphorylation to 
occur. Lys274 also seems to take part not only in the initial steps of phosphorylation but also 
phosphate elimination. Other residues essential for phosphate elimination are Arg506 and Thr512 
of the Kinase-activation domain. Residues Asn352 and Asp 364 are also conserved and seem to 
interact with ATP through a Magnesium ion. Other residues have been identified for LanM activity 
based on additional mutagenesis studies of a different LanM enzyme, BovM. These include 
Tyr230, Glu266, Glu446, and Gln495 in BovM that correspond to Tyr330, Glu366, Glu555, and 
Gln611 in CylM7. 
 
 
Figure 5 Dehydration through phosphorylation catalyzed by CylM. Adapted from Repka et al, 20177.  
 
LanM C-terminal cyclization domain. LanM C-terminal cyclization domain is analogous to LanC 
proteins, shares certain structural features and uses a metal ion cofactor indicating that the 
cyclization reactions should be highly similar (Figure 4).  
The cyclase domain in CylM shares with NisC the histidine and two cysteine conserved residues 
that encapsulate the Zinc ion25. In CylM these residues are Cys875, Cys911, and His912. Many 
LanMs contain three cysteine ligands for zinc instead of two cysteine ligands and the one 
histidine. LanM identified in Euryarchaeota are all part of this group7. The LanM cyclization 
domain also contains a conserved histidine residue as do LanC enzymes, suggesting a function for 
the residue. In NisC the histidine is located at position 212 in CylM in 790. The conservation of 
these residues in novel putative enzymes might indicate preservation of biological activity.  
Enzymes are typically highly stereoselective catalysts that enforce a specific conformation on their 
substrates during the reaction. This usually means that a particular enzyme acts on specific 
substrates to obtain a particular reaction product. The cyclization events aided by some LanMs 
appear to differ from this norm. Some enzymes seem to be able to recognize a high number of 
different substrates and allow for a specific chemical structure for each and every one of the 
substrates. Other enzymes are responsible for the different stereoisomery in the same peptide 
which is highly intriguing given the existence of a single active site for the cyclization8.  This raises 
the question – are ring topologies determined exclusively by the enzymes, by the substrates or by 
a combination of both? As stated above, Dha and Dhb non enzymatic reaction with cysteine 
seems to possess different reaction rates that might result in incorrect lanthipeptide ring 
topology. What also happens, in works where the sequence of the lanthipeptide was altered and 
subject to enzymatic activity to study the final products, is that the substrate controls the 
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steroselectivity of the enzyme26. What seems to be at play is a mixture of substrate and enzyme 
regulation of the final lanthipeptide structure. This type of control is to this day very difficult to 
replicate by chemists1. This control of stereoisomery by LanM enzymes might have very 
interesting biotechnological applications someday. 
 
1.2.2.3 Class III e IV lanthipeptides 
These are the two most recently discovered classes of lanthipeptides and whose trifunctional 
enzymes (with a kinase, lyase and cyclase domains) share the same distinct dehydration 
mechanism. The cyclization domain in class IV enzymes is similar to the LanM and LanC but class 
III shares no homology with the rest27,28. Class III enzymes receive the designation LanKC. Class IV, 
LanL8. Class III lanthipeptides have another interesting feature, the labionin rings (Lab)29. These 
rings are formed through the incorporation of two different cross-links into the peptide. One is 
the carbacyclic ring in an N-terminal position and the other the thioether ring positioned in the C-
terminal.  
 
Dehydration via phosphorylation by two active sites. Dehydration of class III and IV 
lanthipeptides is achieved by two separate kinase and lyase domains present in each enzyme. 
Although no x-ray structures were determined at this point for these classes of biosynthetic 
proteins, in vitro and mutational studies revealed interesting information about these enzymes 
and their particular domains. First, unlike class II, there’s no specific phosphate donor, meaning 
that there isn’t a sole requirement for ATP. Different class III enzymes have different nucleoside 
triphosphate preferences. Some are even capable of using various nucleosides7.  Having two 
active sites, one for phosphorylation of the substrate and another for phosphate elimination, 
means that the dehydration reaction is also not as linear as in class II. A study on the modification 
of the class III lanthipeptide curvopeptin by CurKC revealed that although the events seem to 
occur in a general CN directionality, phosphorylation of different residues is not immediately 
followed by phosphate elimination30. The modified substrate, either by phosphorylation or 
complete dehydration of particular residues determines which domain, kinase or lyase, will be 
acting. This interplay between active sites seems to play a relevant role for correct ring formation 
as incubation of a precursor peptide exclusively with the kinase domain of an enzyme, only then 
followed by incubation of the lyase domain resulted in dehydration inefficacy30.  Several 
mutational studies pinpointed the residues responsible for appropriate dehydration. Various 
residues seem conserved and with a role for phosphate elimination. In SpvC, a class III enzyme, 
Lys136 was pinpointed and in VenL Lys80. His106 in SpvC and correspondent conserved residue in 
VenL, His53, play a critical role also. Another lysine in SpvC, Lys104 with the corresponding 
residue Lys51 in VenL, are also relevant for proper function7. 
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Figure 6 Mechanism for class III and IV dehydration through phosphorylation. In blue are the conserved residues of 
VenL. Image from Repka et al, 20177 
Cyclization domains in class III and IV. The remarkable characteristic of Class III lanthipeptides is 
the presence of not only lanthionine, but also labionin rings catalyzed by the cyclization domain of 
some LanKC, domain that shares no homology with any other class. Although some enzymes 
seem to favor the Lan formation, others appear to favor de labionin structure. Some enzymes 
appear to be capable catalyzing both formations in their respective peptides. Distinction between 
Lab and Lan rings residues is possible based on the reactivity of the dehydrated residues that did 
not cyclized. If a Lan structure is formed, Dhx react with thiols. If a Lab ring is preferred, Dhx lose 
their reactivity7. No proposed model of reaction mechanism is yet available capable of explaining 
this features.  
Class IV LanL cyclase domain shares homology with the metalloenzymes of class I and II and share 
the same ligand site as some LanM enzymes associated with higher activity and ligand tolerance28.  
 
1.3 Leader peptide role and recognition in all classes of 
lanthipeptides 
Although all PTMs being done to the core peptide and lanthipeptide bioactivity being linked to 
leader sequence removal, there’s clear evidence for a role of this N-terminal region sequence in 
the enzymatic reactions and correct final product yield. The leader sequence interacts not only 
with the biosynthetic machinery but it may also interact with immunity and transport proteins in 
the producing organism. 
 
Recognition by LanB and LanC enzymes. Several class I precursor peptides seem to share similar 
number and type of residues in the leader sequence. Mutational studies with NisA revealed a 
conserved motif of four amino acids, PheAsnLeuAsp (FNLD) involved in peptide biosynthesis. 
FNLD motif seems to be essential for LanB recognition while other residues of the leader 
sequence seem to play a role with cyclase LanC interaction. This FNLD-LanB interaction was 
visualized with a crystal structure of NisB in complex with its substrate peptide NisA22. The NisB 
residues Val176, Val198, Tyr202, Leu209 e Tyr213 are responsible for the interaction with 
phenylalanine of the FNLD motif. Il171, Tyr213 and Leu217 interact with the leucine residue. 
Finally, Arg154 with the asparagine one7. The FNLD motif is located in the N-terminal half of the 
leader peptide and the residues of the C-terminal region appear to be a spacer that enables the 
core peptide access to the catalytic site of the LanB responsible for glutamylation. 
Recognition by LanM enzymes. CylM is the first enzyme to have a defined crystal structure and 
the domain responsible for leader sequence recognition in class I lanthipeptides seems not to be 
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preserved in class II. This is supported by the differences found in leader sequences of class II 
lanthipeptides. Instead of the characteristic motif FNLD found in class I, class II leader sequences 
are found to have a ELXXBX motif, with B being either hydrophobic residue, Valine, Leucine or 
Isoleucine. And instead of a N-terminal positioning, this motif is located in the C-terminal region 
of the leader sequence7. 
Interestingly, some LanMs were shown to maintain activity even when the leader sequence of 
their original precursor peptides was fused with different core peptides. Although this is not 
always the case for every enzyme, there could be a biotechnological application for the very 
characteristic PTMs done by these proteins. The explanation for this promiscuity is that the leader 
sequence alone induces an active state of the LanM and facilitates precursor peptide 
modification31, even if not the original one. The current model for LanM catalysis dictates that 
leader sequence is responsible for the activation of the enzyme followed by some level of 
recognition of the core peptide for some enzymes, followed by modification. The core peptide 
sequence seems to also influence the order of dehydration reactions and final Lan ring structure7. 
Recognition by LanKC and LanL enzymes. A series of mutational studies revealed the importance 
of the ILELQ motif present in the leader sequence for LanKC recognition32. As is the case in other 
classes, the residues present in the C-terminal region of the leader sequence are important to 
present the core peptide in the active site and allow catalysis. As recognition is done in a separate 
domain from the active site, a number of residues are necessary between the site of recognition 
and core peptide for dehydration to occur32.  
Another motif was found in the leader sequence of RamS that contains an LFDLQ motif similar to 
the ILELQ one. This motif is widely found in class III precursor peptides7. This residue conservation 
might allow for the identification of new putative LanA precursor peptides in novel class III and 
class IV clusters identified by genome mining. 
 
1.4 Additional PTMs overview 
 
1.4.1 Protease and export activity 
RiPPs and in this case, lanthipeptides, are usually not active until the leader peptide sequence is 
removed. This cleavage is usually coupled with mature peptide export from the cytoplasm. 
 
In Class I. Analysis of class I gene clusters like the one belonging to nisin revealed the existence of 
a gene, LanT, whose sequence was homologous to membrane transporters. In fact, these 
transmembrane transporters have a conserved sequence, SpaT-like domain, that shares high 
similarities with ATP-binding proteins and are now known to be part of the ATP binding Cassette 
(ABC) transporter family. The export function of these proteins was confirmed with deletion of 
the gene in producer strains, resulting in loss of cell viability33. Leader peptide sequence is 
essential for peptide transport. The core peptide, modified or not and even if belonging to a 
different precursor peptide presented to the LanT protein as a chimera, seems to have no 
influence in the mechanism of transport, as some substrate tolerance studies showed. What 
seems to also be necessary for a proper efflux of the peptide is an interaction between LanT, LanB 
and LanC meaning that these biosynthetic enzymes must also be associated to the cellular 
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membrane34. As a general rule for class I lanthipeptides, following precursor peptide transport to 
the outside of the cell ensues cleavage of the leader sequence from the precursor peptide. This is 
achieved by a protease usually anchored to the cell wall. Sequence alignments of NisA with other 
nisin-like precursor peptides identified a conserved Gly-Ala-(Xxx)2-Arg-Ile motif, where NisP 
cleaves between the Arginine and Isoleucine residues. The importance of this motif was 
confirmed once again with mutational studies, where alteration of some of the residues resulted 
in loss of protease activity and an immature peptide35. More recently a second type of protease 
associated to the cytoplasm, not selective for the modified product and with a new leader peptide 
recognition motif was identified making more difficult for an easy identification of precursor 
peptides based on sequence homology. A fully modified core peptide seems to also be needed for 
cleavage to occur. 
In Class II. In this class, the protease and transport function are all done by a bifunctional enzyme 
that shares the terminology LanT with class I. These proteins are members of the ABC-transporter 
maturation and secretion (AMS) protein family. Cleavage by the protease domain generally occurs 
after a two glycine conserved motif, the double-Gly motif. Glycine-Alanine and Glycine-Serine 
sequences are also observed variations of this motif. These enzymes seem to have broader 
substrate specificity.  
A new series of secretion proteins were also identified in Gram-negative bacteria clusters. These 
proteins are part of the major facilitator superfamily (MFS)  and are responsible for the efflux of 
the lanthipeptide from the cell7. 
Besides the variation in cluster composition, more recently we are starting to see a blurring of the 
lines in class I and II distinction based on transport and cleavage function as bifunctional enzymes 
were identified in class I lanthipeptides and LanP genes seem regularly present in class II clusters7. 
 
Class III and IV. The removal of the leader peptide of class III and IV lanthipeptides is very 
different from that of class I/II compounds. The most obvious hint is the lack of a gene encoding a 
dedicated protease in these classes’ clusters. The evidence that the same precursor peptide can 
generate a number of different peptides with varying number of residues confirms the lack of 
activity of such protease. It appears that the class III and IV lanthipeptides maturation is done by a 
stepwise trimming of the leader peptides by currently a different class of peptidases36. 
 
1.4.2 Tailoring enzymes  
Class I. Several additional post-translational modifications are present in class I lanthipeptides. 
Particular enzymes that are not necessarily present in the gene cluster introduce these 
modifications. One of such modifications is the addition of an N-terminal lactyl cap to the mature 
peptide. After cleavage of the leader sequence, the exposed N-terminal amino acid suffers a 
series of non-enzymatic modifications culminating in a final enzymatic reaction possible catalyzed 
by an oxidoreductase7. 
Another modification, done this time to the C-terminal region of the peptide, consists of the 
decarboxylation of a cysteine residue. This modification was first identified in 1985 with the 
elucidation of the epidermin structure37. A gene, epiD encoding for a protein belonging to the 
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homo-oligomeric Flavin containing Cys decarboxylase family was responsible for the 
modification37. Several other peptides have the same modification and encode a similar protein in 
their genome.  
Another set of modifications in class I lanthipeptides are tryptophan halogenation and proline 
hydroxylation. These PTM were identified when determining the structure and mode of action of 
microbisporicin38. 
Class II. This class of lanthipeptides seems to harbor a set of additional PTM of its own. One 
characteristic feature is the formation of the unusual D-Amino acids. The prevailing hypothesis 
states that after dehydration of serine, instead of ring formation, a different enzyme is 
responsible for the D-residue formation through hydrogenation. This protein may belong to two 
different families, the zinc-dependent alcohol dehydrogenases family or the Flavin-dependent 
oxidoreductases one 7.   
Cinnamyin, cinnamycin B, duramycin, duramycin B and duramycin C are an exclusive group of 
class II lanthipeptides with hydroxylated aspartate and lysinoalanine in their structure7.  
Finally another unusual modification present in class II peptides is the oxidation of the sulfur 
present in the methillanthionine ring, modification that seems to be catalyzed by a luciferase-like 
Flavin-dependent monoxygenase protein39. 
Class III and IV. Until now, only two types of PTM other than dehydration and cyclization were 
identified in class III and IV. They are disulfide bond formation and glycosylation. The sulfur bridge 
between cysteines has to be catalyzed by a disulfide isomerase, but the gene for the enzyme has 
yet to be identified, since it’s not present in the cluster29.  The glycosylation is done to a 
tryptophan of labionin-containing NAI-112 and is the first and only reported case of a glycosylated 
residue in lanthipeptides, making this PTM exclusive of class III peptides40. 
Overall, besides the characteristic ring and dehydrated amino acids, the additional PTMs present 
in all classes of lanthipeptides contribute to a broader diversity of molecules and are sometimes 
essential for their characteristic bioactivities. 
 
1.5 Immunity proteins 
Many lanthipeptides are lantibiotics and have potent antibiotic activity that can also be harmful 
for the producing organism. Therefore, they need to be handled by special proteins also encoded 
within the biosynthetic clusters and that constitute their self-immunity system. 
 
For class I. Lantibiotics like nisin act by interacting with lipid II. The strategy found by many 
organisms towards immunity is to limit said interaction with their cell wall. One mechanism relies 
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on a complex of three proteins for the efflux of the mature peptide present in the cytoplasm. 
Those proteins are encoded by lanFEG. NisF and NisE show strong homology to members of the 
family of ATP-binding cassette (ABC) transporters41. NisG encodes a hydrophobic protein that 
allocates this complex to the membrane. Although ingenious, the LanFEG transporter system is 
not a universal mechanism of immunity, as some organisms lack this locus in theirs biosynthetic 
clusters. Another strategy for autoimmunity relies on the sequestering of the lantibiotic in the 
extracellular space. This is achieved by a lipoprotein anchored to the cytoplasmic membrane. 
These proteins usually receive the designation LanI in the cluster18. Although they can act alone, 
these lipoproteins can also contribute cooperatively to full immunity with the respective LanFEG-
related complexes18. Again, this lipoprotein is not present in all clusters, and the molecular means 
by which the producing strains achieve autoimmunity without any of these genes are still not 
clear7. 
For class II. Several class II lanthipeptide clusters also encode LanEFG proteins and LanI. Although 
a special case occurs in this class of peptide. As in LanEFG and LanI cooperation towards full 
immunity, NukH, an immunity protein for Nukacin produced by Staphylococcus warneri ISK-1, 
works in cooperation with the NukFEG complex. This new immunity protein appears to be similar 
to other LanI except in some key aspects. except in some key aspects: i) NukH is rather small 
compared to the other LanI peptides, ii) NukH seems to be anchored to the cytoplasmic side of 
the membrane and iii) NukH appears to have broader substrate specificity42.  
Another unique type of immunity in class II is found in the cinnamycin producing strain, 
Streptomyces cinnamoneus DSM 40646. This lantibiotic exerts its function by binding to 
phosphatidyl ethanolamine, instead of lipid II. The mechanism developed by this organism 
towards immunity involves methylation of the cinnamycin target by a methyltransferase. This 
enzyme is encoded by the cinorf10 gene and its activity was confirmed with heterologous 
expression in E. coli which resulted in methyllated phosphatidyl ethanolamine accumulation and 
resistance to the cinnamycin related lantibiotic, duramycin43. Interestingly, this immunity 
mechanism does not appear to be universal as a homologue of cinorf10 was not found in the 
genome of Streptomyces cinnamoneus ATCC 12686 the producer of duramycin. How the organism 
defends itself against the duramycin it produces is currently not known7. 
 
1.6 Regulation 
Lanthipeptide synthesis is an energy intensive process that needs to be tightly regulated. Several 
mechanisms were developed by producing organisms to control peptide biosynthesis. The 
prototypical lanthipeptide nisin is regulated by a two-component system NisRK13. NisK is a 
cytoplasmic membrane bound kinase that recognizes nisin. When the mature peptide binds to 
NisK, a cascade of events is unfolded. NisK starts with autophosphorylation, then following the 
phosphorylation of the second component of this system, NisR. NisR is a transcriptional factor 
that binds to the promoter regions of the biosynthetic cluster and induces synthesis13. The nisRK 
operon is independent of this nisin autoregulation, as NisK and NisR seem to be continuously 
produced44. Several other lanthipeptides  like subtilin, mersacidin and salivaricin A were reported 
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to have a similar auto regulated two-component system4. Another adopted strategy by producing 
organisms relies on a single regulator protein. In the case of lacticin 3147,  a constitutively 
expressed transcription factor controls biosynthesis and a second transcriptional repressor 
encoded by ltnR regulates expression of the immunity proteins45. A combination of the two was 
also confirmed. In the case of mersacidin it was reported that peptide biosynthesis is regulated 
solely by MrsR1 and immunity proteins were regulated by a two component system, MrsR2/K246. 
Allied to this mechanisms, there are also several other factors to consider. Cell cycle seems to play 
a role in biosynthesis regulation. Several regulatory systems involved in different cell phases may 
also act on the biosynthetic clusters. Growing conditions may also dictate the expression of 
peptides. For instance production of the virulence factor cytolysin is stimulated in the presence of 
the target cells4. Regulation can be therefore highly intricate and the discovery of new 
mechanisms is to be expected. 
 
1.7 Genome Mining 
Next generation sequencing and turn of the century genome sequencing efforts allowed for the 
exponentially increasing publicly available number of bacterial genomes. Meaning that in addition 
to traditional microbiological approaches, in silico screening strategies may now be employed in 
the discovery of new natural products. Taking advantage of the highly conserved nature of 
lanthipeptide biosynthetic enzymes, their organization in clusters and direct connection between 
peptide and corresponding gene (Figure 7), genome mining has proved highly prolific in 
identifying and isolating new compounds directly from  producing organisms or through 
heterologous production systems – a bottom-up approach. The new information gathered also 
facilitates new discoveries in a more traditional approach. A top-down discovery, when a relevant 
biological activity is firstly identified, then a screening or even sequencing of the producer 
organism genome allows to identify the possible biosynthetic machinery at play.  It’s a mixture of 
these methods that allowed for the explosion of new and varied RiPPs47.  
There are some limitations for genome mining. Firstly, there’s very limited information about the 
biological activity of the natural product newly identified in silico. Secondly, genomic screening is 
limited to the knowledge available about protein families and activities. If new biosynthetic 
enzymes with completely unrelated structures to the ones already identified are at play, they will 
remain unknown. Only a continued effort to identify new compounds will reduce the present gap 
in knowledge. And finally, the precursor peptide’s gene and some of its biosynthetic machinery 
might not be neatly organized in a characteristic cluster making it difficult to associate a precursor 
peptide to its biosynthetic machinery.  
Nevertheless, these characteristic clusters of RiPPs and lanthipeptides biosynthesis makes them 
excellent targets for bioengineering explorations. Recent efforts using PSI-Blast to identify new 
homologue biosynthetic proteins in all publicly available genomes aided with readily available 
genome mining tools developed specially for RiPPs, among them being BAGEL248 and antiSMASH49 
that screen for putative peptides based on a large set of search criteria, were returned with 
positive results.  
16 
 
 
 
Figure 7 Gene cluster representation from class I and class II lanthipeptides. Example from Nisin and Lacticin 481. In 
green are the genes responsible for ring formation and lanthipeptide classification. In class I those are the lanB and lanC 
genes. In class II is the lanM gene. lanT and lanP genes are usually responsible for export and cleavage of the precursor 
peptide in class I. A bifunctional lanT assumes that role in class II. In red are the precursor peptides. In yellow immunity 
proteins. lanRK is the two component regulator of nisin. Image adapted from Alkhatib et al,201250. 
1.8 Lanthipeptides heterologous expression in Escherichia coli 
Escherichia coli is a well-established model for heterologous expression and the organism of 
choice in a wide range of applications. There are therefore many molecular tools and readily 
available protocols for highly efficient protein expression. The principal for heterologous 
expression is very straightforward. After selection of the gene of interest follows cloning in an 
appropriate vector. After induction, the protein is purified in the varied ways developed to so far, 
one of them being IMAC (Immobilized metal affinity chromatography). After this, characterization 
ensues. However, many things can go wrong throughout the process. Poor growth of the host 
organism, protein inactivity, inclusion bodies formation or lack of protein production are the most 
common problems encountered51. Giving the wide distribution of the biosynthetic clusters in all 
domains of life, some of these setbacks are to be expected if heterologous expression in this 
common model is attempted. 
The first reported lanthipeptide modified in E. coli dates back to 2005, with the works of Nagao et 
al where they coexpressed a His-tagged nukA peptide with the class II nukM enzyme in a single 
plasmid vector52. Class I peptides have also been modified within a E. coli model, where nisA was 
cloned together with nisB in a vector and nisC on a second plasmid, yielding a fully modified nisin 
precursor peptide20. The E. coli expression system is now considered an appropriate method to 
produce lanthipeptides and in conjunction with in vitro studies contributed to furthering the 
knowledge of these biosynthetic clusters.  
1.9 The third domain of life – Archaea  
Classical systematics relying not only on complex morphological but also physiological studies and 
fossil records give a limited view on the evolution of life on earth. What was at first an incomplete 
view of life that classified all organisms either as a plant or as an animal, with the discovery of 
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bacterial organisms a new equally incomplete view of life emerged as eukaryotic vs prokaryotic. 
The availability of molecular tools by mid twentieth century made it possible to establish a real 
evolutionary relationship between organisms and give a more appropriate order to the diversity 
of life. Carl R. Woese believed this by stating that an ‘organism’s genome seems to be the 
ultimate record of its evolutionary history’53 and shook the taxonomic world with a 
groundbreaking work published in 1977. Using ribosomal RNA sequence as a tool to detect 
phylogenetic relations between organisms revealed the existence of a distinct third group, 
thought until then to be part of the prokaryotes based on classical methodologies. They termed 
that group Archaea. Later on and based on these molecular studies of evolutionary relationships, 
Woese et al (1990) proposed the revamping of the outdated and misleading views on Taxa with a 
new formal system of classification based on the three domains of life: Eukarya, Archaea and 
Bacteria54. Although being quickly attributed to extreme environments, the Archaea are now 
known to be metabolically diverse organisms coexisting in various environments with Eukarya and 
Bacteria, contributing even with considerable biomass in some cases. Genome sequencing 
revealed that Archaea contain a mix of bacterial and eukaryotic features. Their information 
processing mechanisms resemble the eukaryotic ones, while the core metabolic functions are 
similar to bacteria. This is not a strict rule, as many exceptions exist. Similar information 
processing mechanisms means, for instance, that the archaeal RNA polymerase is closely related 
to RNA polymerase II from the eukaryotic counterpart. Not only are the enzymes similar, they also 
require basal factors for promoter recognition, possessing even homologues for the eximious 
TATA-box binding protein and transcription factor B known from the eukaryotic systems. Despite 
that, the transcription machinery appears to be much simpler in Archaea. There seems to be also 
the presence of bacterial like transcription regulators in archaeal genomes meaning that 
regulation is not entirely eukaryotic like 55. Another area of interest in Archaea is DNA 
recombination and repair. The potential for archaeal studies in the subject was made evident by 
the discovery of a new family of type II topoisomerases in Archaea with homology to proteins 
involved in meiotic recombination56. The study of these enzymes opens the possibility of gaining a 
better understanding of the intricate process of meiosis by eukaryotes. Given their characteristics, 
various other interesting applications are at play.  Archaea have also been used to study DNA 
replication55. Structural characterization of archaeal proteins that evolved for high temperatures 
and saline environments allow for data gathering useful in the study of a range of possible protein 
interactions in various organisms. And finally, there is the biotechnological application where the 
extremophile characteristics of these organisms may allow for a higher yield of a given product. 
But these studies are only possible with the development of the correct molecular and 
biochemical tools and the existence of a proper model organism. Halophilic archaea are able to 
grow in hypersaline environments. The coping mechanism for these extreme conditions rely on 
accumulating high cytoplasmic concentrations of potassium. For the enzymatic machinery to 
function in this high salt concentration within the cell, evolution worked towards reducing 
hydrophobicity of these proteins and increasing the number of acidic residues on the protein 
surface57. The negative charge rich surface interacts with cations in solution, allowing for a 
solvated state of the protein. This ability can be a set back with the use of model organisms like E. 
coli and their extensively developed manipulation tools. Halophilic enzymes in E. coli environment 
can be misfold and aggregate in inclusion bodies that would then require, besides the purification 
steps, the denaturation followed by  protein refolding in appropriate conditions58. This can now 
be circumvented with the use of the model organism for Archaeal genetics, Haloferax volcanii. 
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The development of selectable markers59, gene knockout systems60 and promoter 
characterization allowed for the development of specific strains and plasmid vectors essential for 
protein studies61. Haloferax volcanii revealed itself to be even a greater choice for the production 
of halophilic proteins for the various biotechnological purposes, with the development of suitable 
expression protocols62. 
1.10 Haloferax mediterranei 
Haloferax mediterranei is a halophilic organism of the Halobacteriaceae family, domain Archaea. 
It was first isolated in 1980 from salt water evaporation ponds near Alicante, Spain63. Being a 
halophilic organism is capable of growth in a varied range of high salt concentrations. The 
formation of opaque to pink colonies is associated with pigment production that in the first 
isolation report stated to vary according to salt concentration. A seemingly unique characteristic 
of this particular organism63. Other interesting attributes noted were the absence of complex 
nutrient requirements, rapid growth rates and nutritional versatility all relevant factors for growth 
in the microbiologist laboratory63. 
Studies on a varied number of metabolites from this archaeon and a potential for industrial 
application led to the necessity of its genome sequencing in 201264. The genome of Haloferax 
mediterranei ATCC 33500 consists of one chromosome and three megaplasmids. Comparison with 
the archaeal model genome, Haloferax volcanii, reveals high homology between the 
chromosomes and a divergence on the plasmids64.  
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1.11 Work Objectives  
 
Lanthipeptides are an ever growing family of natural products. Lanthipeptide´s activity was once 
thought to be restricted to antibiotics, but since then the activity spectrum and clinical 
applications of these peptides have been extended. In silico analysis identifies their biosynthetic 
enzymes in all domains of life. However, and so far, no lanthipeptides have been described in the 
Domain Archaea. Focused in class II enzymes genes present in Archaea, this work has focused on 
the identification of new biotechnologically interesting molecules and enzymes in this 
underexplored domain. 
To that end, three primary objectives were established: 
i) Identification of lanthipeptides clusters in Archaea, using bioinformatics tools and 
databases publicly available.  
ii) Characterization of the identified clusters followed by comparison with other known 
lanthipeptides clusters.  
iii) Identification of the dehydration pattern in putative lanthipeptides from H. 
mediterranei ATCC 33500, through heterologous expression, peptide purification and 
mass spectrometry analysis. 
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2. Materials and Methods 
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2.1 Bioinformatics 
Novel putative lantibiotic modifying enzymes were identified using Position-Specific Iterated 
BLAST (PSI-BLAST) of the lanthipeptide synthetase CylM with accession number AAK67266.1 in a 
search at National Center for Biotechnology Information (NCBI) Database 
(https://www.ncbi.nlm.nih.gov/). The initial Blast search was limited to the Archaea domain and 
the standard algorithm parameters were used. Two more iterations followed. All relevant hits 
were examined.  
Manual search for putatitive precursor peptides was done using ORFfinder 
(https://www.ncbi.nlm.nih.gov/orffinder/).  
The genomes encoding for the identified LanMs were analyzed using Bagel348 
(http://bagel.molgenrug.nl/index.php/main) for the purpose of identifying the respective gene 
clusters. TMHMM (http://www.cbs.dtu.dk/services/TMHMM) was used to predict 
transmembrane helices and InterPro65 for protein domain analysis . 
The sequence Similarity Network (SSN) was obtained by the online Enzyme Function Initiative-
Enzyme Similarity Tool (EFI-EST)66 using as reference the Pfam of LanM enzymes (PF13575), an e 
value of -10 and an alignment score corresponding to 35% identity. The SSN was then visualized 
using Cytoscape67. 
 
2.2 Media and growth conditions 
Haloferax mediterranei ATCC 33500 was grown at 37ºC in a medium containing 156 g L−1NaCl, 13 
g L−1MgCl2.6H2, 20 g L−1 MgSO4 . 7H2O, 1 g L−1 CaCl2 . 6H2O, 4 g L−1 KCl, 0.2 g L−1NaHCO3, 0.5 g 
L−1NaBr, 5 g L−1  Yeast extract and 1 g L−1 Glucose. 
Haloferax volcanii H1424 was grown in Hv-YPC medium (144 g L−1 NaCl, 21 g L−1 MgSO4·7H2O, 18 g 
L−1 MgCl2·6H2O, 4.2 g L−1 KCl, 5 g L−1 yeast extract, 1 g L−1 peptone from meat, 1 g L−1 casamino 
acids, 12mM Tris, pH 7.5, 3mM CaCl2 added after sterilization) at 45ºC. For solid media, agar was 
added to a concentration of 15 g L−1 and was heat dissolved before adding the peptone from 
meat, yeast extract and the casamino acids. The medium was then autoclaved and CaCl2 added. 
When required, thymidine was added to a concentration of 40 μg mL-1. 
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Escherichia coli DH5α and BL21-Gold (DE3) strains were grown in Luria Bertani medium containing 
the appropriate selective markers. 
 
2.3 DNA extraction 
The extraction of DNA from Haloferax mediterranei ATCC 33500 was performed with the DNeasy 
Blood and Tissue kit (Quiagen) using the protocols recommended for Gram negative and Gram 
positive bacteria. After electrophoresis analysis, both protocols proved to be effective. 
Plasmid DNA was extracted with the GeneJET Plasmid Miniprep Kit (Thermo), according to 
manufacturer’s instructions. 
 
2.4 E.coli co-expression system 
2.4.1 medA and medM amplification and plasmid construction for E. coli expression 
The pRSFDuet-1 plasmid allows co-expression of two genes due to its two multiple cloning sites 
(MCS). The medA genes were amplified from H. mediterranei genomic DNA with primers with the 
appropriate adaptors to allow the expression of a N-terminal His6-tagged precursor peptide at the 
MCS-1. medM genes were amplified for MCS-2 insertion. The primers used are listed on Table 1. 
Reaction components and conditions are described in table 2 and 3, respectively.  
Table 1 Primers used for gene amplification by PCR for E. coli expression. The enzymes shown were the enzymes used 
for cloning and the Ta represents the temperature of annealing used in each PCR reaction. 
Gene Enzymes Primers Ta Amplification (bp) 
medA1 
BamHI 
NotI 
5’ atgaggatccgtcggtagtactcgacatcg 3’ 
5’ cgatgcggccgcttagaaatcgcaggtatggca 3’ 
66ºC 170 
medM1 
NdeI 
XhoI 
5’ agtacatatgacacagcagcttgcagc 3’ 
5’ cgatctcgagttactccagcagaagcacacag 3’ 
63ºC 3161 
medA2 
BamHI 
NotI 
5’atgaggatccgtcccctccgtgtccccta 3’ 
5’cgatgcggccgcttagcatatcagacatctgaa 3’ 
66ºC 227 
medM2 
NdeI 
XhoI 
5’ agtacatatgaaccgcgtctacacgatg 3’ 
5’ cgatctcgagttactcaagcaagagaacgga 3’ 
62ºC 3209 
medA3 
BamHI 
NotI 
5’ atgaggatccgtcagcatatcagacatctg 3’ 
5’ cgatgcggccgcttactgagtatccgtgatgca 3’ 
65ºC 212 
medM3 
NdeI 
XhoI 
5’ agtacatatggcgggcgtatttactgag 3’ 
5’ cgatctcgagttattcccagcgtaacacgtt 3’ 
62ºC 3239 
Table 2 PCR reaction used for amplification of genes. 
Reagents Final concentration Volume (µL) 
10x Reaction Buffer 1x 5 
10 mM dNTPs mix 0.2mM 1 
10 µM Primer Fw 0.3 µM 1.5 
10 µM Primer Rv 0.3 µM 1.5 
Template DNA 10 ng 1.0 
NZYProof DNA polymerase 2.5 U/µL 0.05 U/µL 0.5 
dH2O - Up to 50 
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Table 3 PCR conditions used for gene amplification. * represents the Ta used in each reaction and that is shown in 
Table 1. 
 Temperature Time  
Initial denaturation 95ºC 3 min  
Denaturation 95ºC 30 s 
30 
cycles 
Annealing *ºC 30 s 
Extension 72ºC 60s/kb 
Final Extension 72ºC 10 min  
 
 
After amplification, 1 μg of each PCR product and 1 μg of plasmid were digested with FastDigest 
enzymes (Thermo) according to the recommended protocol. After digestion, the fragments were 
purified from the agarose gel with the QIAquick Gel Extraction Kit (QIAGEN). The resulting 
digested PCR products and plasmids were ligated in a 3:1 molar ratio proportion with 1U of T4 
DNA ligase and 50 ng of the vector (Thermo Fisher Scientific). The reaction was performed at 22°C 
for 1h; 5μl of the ligation  used to transform chemically competent E. coli DH5α by heat shock. 
Clones were selected on LB agar plates containing kanamycin (100 mg mL-1). Positive clones were 
screened by colony-PCR using the universal primers described for MCS1 or MCS2. All the positive 
plasmids were sequenced at STAB VIDA, Lda services, to confirm the absence of mutations. 
 
2.4.2 Co-expression and purification of the medA and medM products 
After transformation of E. coli BL21-Gold(DE3) with the plasmids constructed, single colony 
transformants were grown overnight at 37º in 5 mL of Terrific Broth (TB) medium supplemented 
with kanamycin (100 mg mL-1). The cells were then transferred to 60 mL of fresh TB medium and 
grown at 37ºC until O.D600 ~0.7-0.8. At this stage, IPTG was added to a final concentration of 
0.3mM. The culture was then incubated at 37ºC and/or 18ºC overnight. Cells were harvested by 
centrifugation at 4000 rpm for 15 minutes. The peptides were purified from E. coli pellets using a 
well-established protocol for His6 tagged LanA peptides68 and a 1 mL Hitrap chelating HP nickel 
affinity column (GE Healthcare). C4 Solid phase extraction (SPE) was used for sample desalting 
before mass spectrometry analysis, as described in section 2.6. 
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2.5 Haloferax volcanii expression system 
2.5.1 medA and medM amplification and plasmid construction for Haloferax volcanii co-
expression  
The plasmid used, pTA1392, and the Haloferax volcanii H1424 strain were kindly provided by 
Professor Thorsten Allers of the Institute of Genetics, School of Biology from the University of 
Nottingham. The plasmid has only one promoter, followed by a MCS. In order to mimic the Duet 
system, the final plasmid was constructed in two steps: i) firstly, all medA and medM genes were 
amplified and cloned into pTA1392 MCS and ii) secondly, the pTA1392 MCS containing medAs was 
amplified and cloned in pTA1392 plasmids already containing medM genes. The DNA sequences 
of the genes of interest were amplified harboring the appropriate flanking sequences for multi 
cloning site insertion. The medA genes were individually inserted in a first plasmid using 
restriction enzymes allowing for the His6Tag residues to be transcribed at the N-terminal of the 
peptides. The medM genes were inserted in the same plasmid using the appropriate restriction 
enzymes. In the second step, the promoter and the cloned medA genes were amplified by PCR 
with the appropriate flanking sequences using the newly constructed plasmids (pTA1392 with 
medA genes) as template. This entire sequence was then cloned in the plasmid containing the 
medM of interest. The amplification of genes, digestion and ligation was performed as described 
in section 2.4. All primers used are listed in Table 2. Positive colonies, ampicillin resistant cells 
(100 mg mL-1), were screened by colony-PCR. The absence of mutations in all the genes inserted 
in the plasmids was confirmed by sequencing at STAB VIDA, Lda. 
 
Table 4 Primers used for gene amplification by PCR for Haloferax volcanii expression. 
Gene Enzymes Primers Ta 
Amplification 
(bp) 
medA1 
NspI 
BamHI 
5’ atgaacatgtggtcggtagtactcgacatcg 3’ 
5’ cgatggatccttagaaatcgcaggtatggca 3’ 
62ºC 169 
medM1 
NdeI 
NheI 
5’ agtacatatgatgacacagcagcttgcagc 3’ 
5’ cgatgctagctcactccagcagaagcacacag 3’ 
64ºC 3164 
medA2 
NspI 
NotI 
5’ atgaacatgtggtcccctccgtgtccccta 3’ 
5’ cgatgcggccgctcagcatatcagacatct 3’ 
66ºC 228 
medM2 
NdeI 
BamHI 
5’  agtacatatgaaccgcgtctacacgatg 3’ 
5’ cgatggatccctactcaagcaagagaacgga 3’ 
62ºC 3209 
medA3 
NspI 
BamHI 
5’ atgaacatgtggtcagcatatcagacatctg 3’ 
5’ cgatggatccctactgagtatccgtgatgca 3’ 
62ºC 211 
medM3 
NdeI 
NheI 
5’ agtacatatggcgggcgtatttactgag 3’ 
5’ cgatgctagctcattcccagcgtaacacgtt 3’ 
62ºC 3239 
Ptna promoter + medA1 
NheI 
BamHI 
5’ cgatgctagccgctctcgaagctgtttc 3’ 
5’ cgatggatccttagaaatcgcaggtatggca 3’ 
64ºC 404 
Ptna promoter + medA2 
BamHI 
NotI 
5’ cgatggatcccgctctcgaagctgtttc 3’ 
5’ cgatgcggccgctcagcatatcagacatct 3’ 
65ºC 463 
Ptna promoter + medA3 
NheI 
BamHI 
5’ cgatgctagccgctctcgaagctgtttc 3’ 
5’ cgatggatccctactgagtatccgtgatgca 3’ 
64ºC 446 
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2.5.2 Haloferax volcanii H1424 transformation  
The plasmids constructed in the previous section were used to transform H. volcanii H1424. 
Transformation was performed by the spheroplast formation in polyethylene glycol 600 method 
described by Cline and Doolittle69. Selection is possible due to the highly engineered nature of the 
strain H1424. This strain lacks the pyrE2 gene encoding for an enzyme essential for pyrimidine de 
novo biosynthesis. Successful transformation reintroduces this gene in the organism, allowing 
growth in medium lacking thymidine. All strains obtained from transformation are summarized in 
table 7. 
 
Table 5 Summary of all strains obtained from transformation. 
Strain Description 
H1424_medA1 pTA1392 containing medA1 gene N-terminally fused to an His6Tag 
H1424_medM1 pTA1392 containing medM1 gene 
H1424_medA2 pTA1392 containing medA2 gene N-terminally fused to an His6Tag 
H1424_medM2 pTA1392 containing medM2 gene 
H1424_medA3 pTA1392 containing medA3 gene N-terminally fused to an His6Tag 
H1424_medM3 pTA1392 containing medM3 gene 
H1424_medM1A1 pTA1392 containing medM1 gene and medA1 gene N-terminally fused to 
an His6Tag 
H1424_medM2A2 pTA1392 containing medM2 gene and medA2 gene N-terminally fused to 
an His6Tag 
H1424_medM3A3 pTA1392 containing medM3 gene and medA3 gene N-terminally fused to 
an His6Tag 
 
  
2.5.3 MedAs expression in Haloferax volcanii H1424 
The protocol described by Strillinger et al 62 was adopted for our convenience. Haloferax volcanii 
transformed with the desired plasmid was initially grown in 20mL of Hv-YPC broth at 45ºC and 
180 rpm for 24 hours. This initial culture was then diluted to a final OD610nm of 0.005 in fresh 
medium, for a final volume of 100mL. The cultures were left to grow in the same conditions until 
OD610nm of 0.3. When OD610nm=0.3, tryptophan was added to a final concentration of 6mM. After 
16 hours of incubation, tryptophan was added again to a final concentration of 9mM and the 
cultures were grown for another 4 hours. At this time, the cells were collected by centrifugation 
at 4000 rpm for 15 minutes and suspended in 7 mL of Buffer A (20 mM HEPES pH7.5, 2M NaCl, 20 
mM imidazole). The cells were then lysed by sonication on ice until the suspension was no longer 
as turbid, and centrifuged at 10000 rpm for 15 minutes. The supernatant obtained was filtered by 
a 0.45 μm PES filter. The His6Tag-LanA peptides were purified with a 1 mL Hitrap chelating HP 
nickel affinity column (GE Healthcare). This column was first equilibrated with 5 column volumes 
(CVs) of buffer A. The filtered supernatant was loaded to the equilibrated column and the column 
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was washed with 5 CVs of buffer A. The peptides were then eluted with 2 mL of Buffer A 
containing 100mM imidazole. 
 
2.6 MALDI-TOF Mass spectrometry analysis 
After IMAC purification of peptides produced in E. coli and H. volcanii, the samples were desalted 
using ZipTip C18 or by solid phase extraction (SPE) with a C4 column, before MALDI-TOF analysis in 
a 4800 Plus MALDI TOF/TOF Analyzer (AB SCIEX). 
When ZipTip was used, the ZipTip was equilibrated with 100% acetonitrile (ACN) followed by 0.1% 
trifluoroacetic acid in mqH2O (0,1% TFA). After peptide binding to the ZipTip, it was washed with 
0.1% TFA. The elution of the peptides was performed with a saturated solution of α-cyano-4-
hydroxycinnamic acid (10mg mL-1; CHCA) prepared in 50%ACN acidified with 0.1 % TFA directly to 
the MS plate.  
Desalting by SPE involved the equilibration of the C4 column with 100% ACN followed by wash 
with 0.1 % TFA.  Then, the sample was loaded and washed twice with 0.1% TFA. Elution was 
performed with 70% ACN. After evaporation, the sample was suspended in 0.1% TFA and mixed 
with the saturated solution of CHCA for MS analysis.   
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3. Results and discussion 
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3.1 Identification of CylM homologues in Archaeal genomes 
The enzyme CylM was used as the query sequence for mining of homologues in the Archaea 
domain. CylM is a member of the type 2 lantibiotic biosynthesis protein LanM family. As such, 
CylM is a bifunctional enzyme with a dehydratase domain in its N-terminal region, responsible for 
the dehydration of Serine and Threonine residues, and a cyclase domain in the C-terminal region 
responsible for the formation of the lanthionine/methyllanthionine rings. This cyclase domain 
belongs to the lanthionine synthetase C-like protein family.  
Position-Specific Iterative (PSI)-BLAST is a protein database search program that builds off the 
initial alignment, that is similar to a BLASTp one70. After the first iteration a statistically significant 
alignment is produced from the highest scoring hits of the initial run and this new profile, or 
position-specific score matrix (PSSM) where highly conserved residues receive the highest scores. 
It is used instead of the original substitution matrix for another sequence search. Each iteration 
translates into a refinement of the PSSM. This process allows the discovery of related sequences 
that a simple BLASTp run wouldn’t be able to do.  
The PSI-Blast results gave a total of 25 hits for possible LanM enzymes in Archaeal genomes. From 
these, four hits were discarded based only on the sequence length. Smaller proteins were 
probably homologues of the LanC like domain of our query sequence. These proteins are LanCs 
and not LanMs that are capable both of dehydration and cyclization. Thus, the proteins belonging 
to Haloterrigena mahii, Halophilic archaeon J07HB67 and both of Halopiger djelfimassiliensis were 
not considered for further analysis. 
All the significant hits of putative LanM proteins in the Archaea domain were exclusively detected 
in organisms from the class Halobacteria and are represented in Table 3. The most distinctive 
feature of these organisms is their requirement for high salt concentrations. Some species are 
able to grow at concentrations as low as 1 M NaCl, but most of them grow best between 3.5 and 
4.5 molar concentrations71. The mechanism behind the tolerance to this environment seems to be 
the accumulation of KCl in the cell and therefore their enzymatic machinery evolved to have the 
highest activity at high levels of KCl71. Nearly all species possess distinctive red, orange or pink 
pigmentation. 
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Table 6 CylM homologues identified by PSI-Blast. All organisms belong to phylum Euryarchaeota, class Halobacteria. 
  Organism Protein accession number Genome RefSeq Locus tag 
H
al
o
b
ac
te
ri
al
es
 Ha
lo
ba
ct
er
ia
ce
a
e 
Haladaptatus 
Haladaptatus cibarius D43 
WP_049969213.1 
GCF_000710615 
HL45_RS00765 
WP_049972812.1 HL45_RS19115 
WP_049971341.1 HL45_RS12075 
Haladaptatus paucihalophilus DX253 WP_007983023.1 NZ_AQXI00000000 B208_RS0118315 
H
a
lo
a
rc
u
la
ce
a
e 
Haloarcula Haloarcula argentinensis DSM 12282 WP_049943790.1 NZ_AOLX00000000 C443_RS00600 
Halomicrobium Halomicrobium mukohataei DSM 12286 WP_015761762.1 GCF_000023965 HMUK_RS03740 
unclassified Halobacteriales 
halophilic archaeon J07HB67 
ERH12559.1 
424 aa 
GCA_000416105 
 
J07HB67_01580 
halophilic archaeon J07HX5 ERG89078.1 GCA_000415945 J07HX5_01230 
H
al
o
fe
ra
ca
le
s 
H
a
lo
fe
ra
ca
ce
a
e 
Haloferax 
Haloferax mediterranei ATCC 33500 
WP_004056317.1 GCF_000306765(Plasmid pHM300) HFX_RS15990 
WP_004056313.1 GCF_000306765(Plasmid pHM300) HFX_RS16005 
WP_004057361.1 GCF_000306765 (Chromosome) HFX_RS04210 
Haloferax alexandrinus JCM 10717 WP_049968936.1 GCF_000723845 BN984_RS18090 
Haloferax prahovense DSM 18310 WP_008093839.1 NZ_AOLG00000000 C457_RS08840 
Haloferax denitrificans ATCC 35960 WP_004967897.1 NZ_AOLP00000000 C438_RS03580 
Haloferax gibbonsii ATCC 33959 WP_050460258.1 
NZ_CP011949 
(Plasmid pHG2) 
ABY42_RS17125 
Haloferax sp. ATB1 WP_042665535.1 GCF_000730175 ATB1_RS15910 
Haloferax larsenii JCM 13917 WP_007538897.1 GCF_900109695 C455_RS00665 
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 Table 8 CylM homologues identified by PSI-Blast. All organisms belong to phylum Euryarchaeota, class Halobacteria (continuation of Table 8). 
   Organism Protein accession number Genome RefSeq Locus tag 
N
at
ri
al
b
al
es
 
N
a
tr
ia
lb
a
ce
a
e 
Natrinema 
Natrinema sp. J7-2 WP_014862558.1 NC_018224 NJ7G_RS00200 
Natrinema gari JCM 14663 WP_049910399.1 NZ_AOIJ00000000 C486_RS10070 
Halobiforma Halobiforma lacisalsi AJ5 
WP_007143049.1 
 
NZ_CP019286 
(plasmid pHLAJ5I) 
CHINAEXTREME_RS20780 
Natronorubrum Natronorubrum tibetense GA33 WP_006092971.1 GCF_000383975 NATTI_RS0124325 
Halopiger Halopiger djelfimassiliensis 
WP_049921103.1 
654 aa 
NZ_CBMA000000000 TX80_RS01480 
WP_049921102.1 
402 aa 
NZ_CBMA000000000 TX80_RS01475 
Haloterrigena 
Haloterrigena mahii 
 
WP_082917683.1 
419 aa 
GCF_000690595 HTG_RS00500 
unclassified Natrialbaceae Natrialbaceae archaeon JW/NM-HA 15 WP_086889213.1 GCF_002156705 B1756_RS14655 
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3.2 Conserved residues between CylM and the putative LanM 
Several residues are conserved not only across LanM but also between LanM and LanC given that 
LanM enzymes possess a LanC like domain responsible for the cyclization reaction. The 
importance of several of these amino acids was confirmed through mutational studies and the X-
ray structure of CylM7,25. A number of conserved residues is expected given the nature of the PSI-
BLAST search. However, the presence of the specific conserved residues known to be involved in 
the dehydration and cyclization reactions was confirmed for all the enzymes through Multiple 
Sequence Alignment (MSA) (Figures 8 and 9). 
 
Residues involved in Dehydration  
In CylM, the amino acids that are thought to be responsible for the activation of the phosphate to 
be transferred from ATP to the substrate in the phosphorylation step are Asp252 and His254. 
However, Lys274, Asp347, His349, Asn352, Asp364 and Glu366 are also involved in 
phosphorylation7. Glu366 is thought to stabilize ATP during the reaction and Asn352 with Asp364 
might interact with ATP through a magnesium cation. In some reported cases, Gln replaces 
His349. All of these residues were present in the LanM of Archaea. Moreover, it was found that 
the majority of the proteins contain the Gln349 instead of His (Figure 8). Other residues were 
reported to be important for LanM activity based on mutagenesis studies. On CylM, these 
residues are Tyr330, Glu555 and Gln611. In Archaea, Tyr330 is conserved across all enzymes, but 
Glu555 is not. Although there is no conservation of the glutamic acid, other charged residues like 
arginine, lysine and aspartic acid are present (Figure 8). Gln611 is conserved in all enzymes but 
one encoded in Haloferax larsenii JCM 13917 genome, where instead of a glutamine there is a 
glutamic acid. Arg506 and Thr512 are important residues for phosphate elimination, the second 
step of the dehydration reaction and they are both conserved in all proteins. 
 
Residues involved in Cyclization  
The cyclase domain in CylM shares with NisC the α,α-barrel fold that encapsulates a Zn2+ cofactor 
by interaction with one histidine and two cysteine residues25. Mutational studies revealed their 
importance for cation binding and consequently cyclization. These residues in CylM are located in 
Cys875, Cys911 and His912. In many LanMs (first reported for ProcM) instead of this motif, they 
contain three cysteine ligands for zinc. Euryarchaeota proteins were found to cluster almost 
entirely within this three cysteine motif group (Figure 9), which is present in all enzymes, except 
for Haladaptus cibarius D43 (WP_049972812.1). In the latter, no cyclization domain was detected. 
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LanC cyclases and the LaM cyclase domains appear to have other conserved His residue7: His212 
for NisC and His790 for CylM. This residue is not conserved in the Archaeal LanM. 
 
 
Figure 8 Multiple sequence alignment of the identified LanMs. Analysis showed strong conservation of the residues 
involved in dehydration. 
 
 
 
Figure 9 Multiple sequence alignment of the identified LanMs shows conservation of the three cysteine ligands for zinc. 
 
The conservation of the three cysteine residues, the lack of conservation for the His790 residue 
and the adaption of these enzymes to high salt concentrations might be the reasons why they all 
seem to cluster together when a sequence similarity network analysis was performed (Figure 10). 
A SSN allows the visualization of sequence relationships between individual members of a large 
protein family and helps map out members of a family that are not well characterized. In Figure 
10, we can clearly outline a cluster composed by the archaeal LanM enzymes. 
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Figure 10 Sequence similarity network of LanMs generated using EFI-EST and visualized in Cytoscape with an alignment 
score threshold of 110(∼35% sequence identity). 
 
 
3.3 Search and analysis of the putative archaeal precursor peptides 
Genome mining tools rely on a set of parameters for the identification of the putative precursor 
peptides based on the knowledge involving the peptide sequence and the known biosynthetic 
clusters organization. These genome-mining tools are of utmost importance. However, very often 
they do not detect the genes encoding precursor peptides. This is mainly due to the fact that they 
are normally small genes that are not annotated in the publicly available genomes. Nevertheless, 
new promising tools are being developed towards mitigating these limitations72 that might prove 
highly effective in future research.  
The majority of the precursor peptides are encoded near their corresponding modification 
enzyme. Thus, when a putative peptide was not annotated nearby the protein detected, we 
searched for their presence “manually” using ORFfinder. This allowed us to identify open reading 
frames that coded for small peptides containing serine, threonine and cysteine residues that are 
essential for lanthionine ring formation. Assuming that this expression is highly regulated and that 
LanA and LanM can be coexpressed in the same operon7, peptides encoded in the same 
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orientation of LanM were favored. With this approach, it was possible to detect lanA genes in all 
the archaeal genomes with lanM genes. We then compared all of the peptides in order to 
evaluate if they share some conserved motifs. This analysis could also help in the detection of a 
pattern that could allow the differentiation between their core and leader sequences (Figure 11). 
 
 
Figure 11 Multiple Sequence Alignment of all manually identified putative precursor peptides. In brackets are the four 
distinct groups identified. 
 
Peptide alignment analysis showed that five distinct groups are formed (Figure 11), numbered 
from I to V. The first group is composed by four peptides identified in Haladaptatus 
paucihalophilus DX253 and the precursor peptide identified in the vicinity of Haloarcula 
argentinensis DSM 12282 LanM. The second group consists of peptides identified in two different 
species of Haloferax (Haloferax larsenii JCM 13917and Haloferax mediterranei ATCC 33500). The 
third group is composed by peptides identified in five different Archaea. The fourth group has 
peptides identified in Halobiforma lacisalsi AJ5 and again in Haloferax mediterranei ATCC 33500 
and Haladaptatus cibarius D43. The H. mediterranei ATCC 33500 peptide is encoded in a plasmid. 
The last group is composed by peptides from different genus that do not share similarity.  
As abovementioned, class II lanthipeptides have some conserved motifs. One of these motifs is 
the so-called double-Gly motif (GG/GA/GS) and is located at the end of the leader sequence. It is 
recognized by the N-terminal papain-like C39 protease of the SunT-type LanT that removes the 
leader sequence and exports the class II lanthipeptides outside of the cells. This type of sequence 
is present in two peptides of the second group and in almost all the peptides of the third group 
(Figure 11). The other conserved motif of class II peptides is ELXXBX, which is essential for peptide 
recognition and correct modification by the LanM enzymes7,8. This motif is not present in Archaeal 
precursor peptides, suggesting that archaeal LanM enzymes may not require these amino acids to 
recognize their cognate peptides.   
 
I 
II 
III 
IV
  I V
  I 
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In order to better understand the four groups sharing some homology, they were independently 
analyzed (Figure 12).  
In the first group of Figure 12, several residues located in the N-terminus region of the precursor 
peptide were conserved constituting a QxxKxxYDxxF motif. Towards their C-terminus, there is also 
a highly conserved AK motif. It can be suggested that this motifs might be responsible for peptide 
recognition and peptidase activity as seen with the common class II ELXXBX and double–Gly 
motifs. Another interesting observation is the fact that several homologous peptides are present 
in the vicinity of Haladaptatus paucihalophilus DX253 LanM. This indicates that this enzyme has a 
high substrate tolerance and can modify, at least, four peptides. It is worth to notice that the C-
terminus of these peptides has few conserved residues. Some LanM enzymes are known to 
modify different peptides with similar leader sequences. The best characterized example is ProcM 
that modify up to 29 different substrates with diverse ring topologies73.  
The second group (Figure 12) is composed by peptides that are very similar and that will also 
originate very similar mature peptides, regardless of being modified by LanM proteins from 
different species. This should imply that their cognate LanM enzymes are very similar as well.  
The third group (Figure 12) also contains peptides encoded in the genome of five different 
species, but that share very high sequence homology. The most dissimilar peptide is from 
Haladaptatus cibarius D43. Even so, all of the organisms have the potential to produce the same 
mature peptide with the sequence TASCYLPCHTASKLPCCDTTN, suggesting that proteolysis can 
occur after the TG/TA motif and not after the GG motif abovementioned. In the N-terminus 
region is possible to identify a TVDK motif that can be responsible for peptide recognition. The 
conservation of the residues D, F, I and E might also indicate a possible function in export and/or 
transport. 
In the fourth group (Figure 12) the motif LKXXFXD in conserved in the N-terminal region that 
might also have a recognition or cleavage function. 
Normally, very identical biosynthetic enzymes modify very identical peptides. Moreover, the 
biosynthesis of closely-related peptides is expected to be similar. Therefore, the comparison of 
the genetic environment of lanA and lanM genes from these different groups can be useful for 
the identification of the enzymes that can be involved in the biosynthesis of lanthipeptides in 
Archaea. With that in mind, identification and comparison of putative clusters using Bagel 
software48 followed.  
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Figure 12 Multiple sequence alignment between the four groups of similar putative LanA peptides. 
  
 
3.3.1 Identification of gene clusters encoding the biosynthesis of Class II lanthipeptides in 
Euryarchaeota  
We used Bagel48, one of the many automated genome mining software available, to define the 
constitution of the possible lanthipeptide clusters (Figure 13).  
The clusters were arranged in four different groups based on the results of the putative peptides 
alignment (Figure 13). A first analysis, shows that they are somehow different from the known, 
classical class II clusters. For instance, there are no genes encoding the bifunctional SunT-type 
LanT, responsible for the transport and maturation of the class II peptides. Nevertheless, we 
identified several ABC transporter-related proteins that can be involved either in transport or 
peptide immunity. 
Different genes compose the gene clusters identified by Bagel. However, this does not imply that 
all of these genes are, in fact, part of the lanthipeptides biosynthetic cluster.   
In the first group, the upstream and downstream genes of lanM are distinct. Therefore, based on 
the genetic context, it is only possible to identify a lanM and lanA gene as part of these clusters 
(Figure 13). 
In the second group, the gene immediately upstream of lanM encodes a protein of unknown 
function (UF; Figure 13), which is likely involved in the biosynthesis of the lanthipeptide. The other 
genes encode metabolic proteins that are also present in Halobacteria genomes without LanMs 
and therefore should not be exclusively involved in the biosynthesis of lanthipeptides. 
Focusing on the third group, it is worth to mention that Bagel failed to retrieve a cluster from the 
Haloferax alexandrinus JCM 10717 genome. The clusters identified for this group were very 
similar, except the one of H. cibarius. The clusters with intra-similarity (H. denitrificans, 
H. prahovense and H. gibbonsii) encode an ABC transporter immediately upstream of lanM genes. 
In H. cibarius D43, a homologue of this ABC transporter is also found upstream of its lanM gene, 
I 
II 
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but is not depicted in the Figure 13 because Bagel did not consider it. Thus, it is highly probable 
that the biosynthetic clusters of peptides from group three, are composed, at least, by a lanM, a 
lanA and two genes encoding an ABC transporter (one encodes the ATP-binding cassette and the 
other the transmembrane domain). The other genes that are very similar in H. denitrificans, 
H. prahovense and H. gibbonsii clusters are not present in the surroundings of H. cibarius lanM. 
This suggests that they must be not involved in the biosynthesis of the lanthipeptides. 
In group four, apart from lanM and lanA, it seems that the three clusters do not share similarity 
among each other. Therefore, as for group 1, it is difficult to infer about the lanthipeptide cluster 
based on similarity. Nevertheless, it is worth to mention that the lanM gene of H. lacisalsi AJ5 is 
embedded in two ABC transporters (Bagel did not identify the permease ORF of one of the ABC 
transporter).  Curiously, the gene immediately downstream of the second ABC transporter and a 
gene located some ORFs upstream of lanM encode transposases. This can suggest that all of the 
genes between the transposases can be important for the biosynthesis of the lanthipeptide. The 
H. mediterranei cluster will be discussed in more detail in the following section. 
Some of the lanA genes identified by Bagel did not correspond to the peptides that were detected 
by “manual” search and described in the previous section. One limitation of Bagel software is the 
use of a particular set of characteristics based on the current knowledge pertaining a natural 
product and its biosynthetic machinery. In some cases, the software did not predict a cluster, in 
others it was unable to identify appropriate lanA genes or components of the ABC transporters. 
Moreover it predicts big biosynthetic clusters that very often contain genes that are ubiquitous in 
Archaea and that, therefore, are not directly related to lanthipeptide biosynthesis. These are also 
disadvantages of other prediction softwares, such as AntiSMASH. Therefore, the automatic 
analysis should be always carefully revised when it is intended to characterize the biosynthetic 
clusters of lanthipeptides (as well as other secondary metabolites). Finally, lanthipeptide 
enzymatic machinery usually cluster together in the genome. Nonetheless, proteins involved in 
the biosynthetic process can also be present somewhere in the genome. 
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Figure 13 Comparison between the four distinct groups of putative gene clusters identified by Bagel. The ABC 
transporters are represented in red,  and in green are represented the putative lanA genes identified by the software. In 
the Haladaptatus paucihalophilus DX253 cluster two lanthipeptide regulation related genes were identified, in yellow. 
Two other genes, in cyan, were also identified as associated with lanthipeptide clusters but with undefined function. 
The Tn represents genes encoding transposases. The black lines represent the minimal genes that should be involved in 
the biosynthesis of each lanthipeptide. 
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3.4 The case study of Haloferax mediterranei ATCC 33500 
Haloferax mediterranei ATCC 33500 received further attention for several reasons. Firstly, it 
encodes a total of three LanMs in its genome, both in the chromosome and in one of its plasmids 
(Figure 14). In the plasmid, the two lanM are contiguous, resembling two component peptides. 
Type II lanthipeptides are notorious for their two component peptides, where each precursor 
peptide is traditionally post translationally modified by a cognate enzyme. However, the 
bioactivity of these peptides depends on their sinergy4. 
In Haloferax mediterranei ATCC 33500, the genes adjacent to the lanMs were analysed in more 
detail (Figure 14 and Appendix 2). For the sake of simplicity, the LanMs genes were termed 
medM1 for the one present in the chromosome cluster and medM2 and medM3 for those present 
in the plasmid. The putative peptides genes followed the same terminology and therefore were 
designated medA1 (present in the chromosome) and medA2 and medA3 (in the plasmid). 
In the chromosome, immediately upstream of the lanA1 gene there is a gene encoding an 
acetate-CoA ligase family protein (HFX_RS04215). This enzyme is part of the core genome of 
various Halobacteria. Thus, lanA establishes the upstream limit of the biosynthetic cluster. 
Immediately downstream of medM1 there is a gene that encodes a hypothetical protein 
(HFX_RS04205) that is not found in other microorganisms and that is probably transcribed 
together with medM1. Further downstream we identified two genes encoding proteins and an 
ABC transporter (HFX_RS04200 to HFX_RS04185) that have highly conserved homologues in most 
of the genomes of Halobacteria species. For this reason, these genes should not be involved in the 
biosynthesis of the H. mediterranei lanthipeptide encoded in the chromosome.  
In the plasmid, immediately upstream of the medM2 there are three genes (HFX_RS15975 to 
HFX_RS15985) that encode proteins with high similarity with proteins that are also encoded in the 
genomes of Halobacteria that lack lanM genes. The same was observed for the oleate hydratase 
(HFX_RS15995) encoded between medM2 and medM3 genes. For this reason, it is probable that 
these genes are not essential for the biosynthesis of MedA2 and MedA3 peptides. Immediately 
downstream of the medM3 gene there are two genes encoding an ABC transporter (HFX_RS16010 
and HFX_RS16015) and a gene encoding a hypothetical protein (HFX_RS16020). ABC-transporters 
are a family of integral membrane proteins transporters widely spread among organisms. They 
are characterized by their nucleotide-binding and transmembrane domains74 . However, very 
frequently the transmembrane domains are annotated as hypothetical proteins. In order to 
confirm the presence of transmembrane domains in HFX_RS16010, TMHMM was used for further 
analysis. TMHMM is a membrane protein topology prediction method based on a hidden Markov 
43 
 
model. It predicts transmembrane helices in proteins and allows distinguish between soluble and 
membrane bound proteins with a high degree of accuracy. The analysis (Figure 14) confirmed that 
the protein encoded by HFX_RS16010 has 6 transmembrane domains. Genes encoding a similar 
ABC transporter and a similar hypothetical protein were identified in Halobacteria containing 
lanM genes. Moreover, they do not seem to be ubiquitous in Halobacteria species. This indicates 
that these genes are involved in the biosynthesis of either MedA3 or MedA2 or even both. The 
nisFEG locus in nisin biosynthethic cluster also have similar ABC transporters. NisF has an ATP-
binding site domain and the transmembrane hydrophobic proteins NisE/G work together for 
peptide excretion from the cell. Therefore, it is not clear if the ABC transporter identified in the 
plasmid biosynthetic cluster can be involved in a putative transport of the lanthipeptides from the 
cells or if, alternatively, they are a self-immunity system. The last hypothesis imply that the 
lanthipeptides encoded in the plasmid have archeocin activity. 
 
 
 
 
 
Figure 14 Schematic representation of the two clusters identified in Haloferax mediterranei. In blue the LanMs genes 
identified. In yellow the putative peptides genes. In red the ABC transporter genes.  
 
Figure 15 Plot generated by TMHMM analysis of the gene HFX_RS16010 coding for the transmembrane domain of an 
ABC transporter. 
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3.4.1 Escherichia coli co-expression of the putative medA and medM genes from Haloferax 
mediterranei ATCC 33500 
E. coli is a well-established model organism for lanthipeptide production. Several studies of 
heterologous co-expression revealed paramount for the identification of several lanthipeptides 
and to understand their respective clusters. With that in mind, the E. coli model seemed 
appropriate for the co-expression of the biosynthetic enzymes identified in H. mediterranei and 
their respective putative precursor peptides. To that end, the pRSFDuet-1 plasmid was chosen as 
the expression vector for this study. One of the multi cloning sites (MCS) was used to house the 
precursor peptide gene (medA1/medA2/medA3), while the other MCS housed the corresponding 
biosynthetic enzyme (medM1/medM2/medM3). The construction was performed in order to 
express a His6Tag fused to the N-terminal of MedAs peptides. This would allow recovering the 
modified peptides by IMAC. The role of this enzyme is the dehydration of the serine and 
threonine residues, followed by cyclization from the attack of cysteine. This dehydration would 
mean an overall decrease in the peptide molecular weight. With each water molecule lost, a 
decrease in 18Da is expected. The serine and threonine residues located in the N-terminal region 
of the peptide, usually associated with the leader sequence, are not expected to be involved in 
the dehydration reaction. But, as no clear distinction between leader sequence and core 
sequence is possible at the moment, all serine and threonine residues present in the precursor 
peptide are considered putative targets for the reaction (marked in red in Figure 16). Based on 
this, it is possible to predict the masses of the different peptides that can result after dehydration 
by MedMs (Appendix 3). When we further analyzed the MedA C-terminus, it is also possible to 
predict that MedA1 has the potential to form three Lan/MeLan rings, MedA2 can form two and 
MedA3 five, based on their number of cysteines (Figure 16).  
 
 
Figure 16 Sequence of the His6-tagged precursor peptides for E. coli co-expression. Colored in red are the serine and 
threonine residues essential for the dehydration reaction. 
 
After co-expression of medA and medM genes and purification by standard methods, the MedA 
peptides were analyzed by mass spectrometry (MS). It was not possible to identify MedA masses 
shift corresponding to dehydration reactions, indicating that MedM enzymes were not active. 
Confirmation of MedM expression after IPTG induction under various conditions was investigated 
by SDS-PAGE of whole cell protein extracts (Figure 17). We confirmed that MedM proteins were 
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expressed, but they are inactive, most probably due to the lack of correct folding in the E. coli 
expression system. Being an Archaeal gene, the transcription of our biosynthetic enzyme can be 
compromised simply due to codon preference of the transcriptional machinery of E. coli. Certain 
archaeal organisms prefer codons recognized by tRNAs that are rarely used in E. coli, making 
transcription and proper folding difficult in this model75. Another known issue of this bacterial 
model is the formation of inclusion bodies meaning that the translated protein ends up an 
agglomerate of precipitated peptides with no utility whatsoever. Moreover, given that the 
MedMs could have evolved to be functional in a high salinity environment, it is possible that they 
misfold in the E. coli cytoplasm. To overcome this issues, in vitro experiments have been used to 
validate PTM activity of multiple LanM enzymes76,77. This approach could be employed to 
investigate the MedMs activity on MedAs. But given the existence of many variables that can not 
be easily addressed, such as ensuring the proper folding of biosynthetic enzymes of our isolates, it 
was decided to change the model organism for co-expression of the genes under study and use 
instead the archaea Haloferax volcanii H1424. 
 
Figure17 SDS-Page of whole cell proteins. The cells harboring the gene 
medM3 were used for protein expression confirmation. Results from 4 and 
18 hours incubation at 37ºC and 18ºC after induction of expression by 
IPTG confirmed expression of our 120 kDa enzyme (arrows). Respective 
negative controls are present. 
46 
 
3.4.2 Haloferax Volcanii H1424 co-expression of the putative medA and medM genes from 
Haloferax mediterranei ATCC 33500 
Haloferax volcanii, isolated from the Dead Sea, is the quintessential model organism for Archaeal 
genetics. Haloferax volcanii  is highly similar to Haloferax mediterranei, as confirmed from 
genome comparison64. The use of similar organisms for heterologous expression should mitigate 
some of the common issues encountered with the E. coli model. Several strategies have been 
applied to engineer H. volcanii strain for genetics studies and heterologous gene expression 
purposes. The H1424 strain is the culmination of several efforts that worked towards that end. 
The vector created for the purpose of protein expression was plasmid pTA1392 and it was used in 
the present work. This plasmid as an inducible tryptophanase promoter (p.tnaA) and a pHV2 
origin of replication that maintains the plasmid at a copy number of approximately ~6 per genome 
equivalent57. Overexpression is induced by the addition of tryptophan to the culture medium. An 
ampicillin resistance gene and a high copy number origin of replication allow for the use of the 
classical methodologies for cloning and plasmid amplification in E. coli. However, pTA1392 has a 
single promoter. Therefore we developed a strategy to use this plasmid for co-expression of medA 
and medM genes where each of these genes is under the control of a p.tnaA promoter. This 
system is described in the following section. 
 
 
3.4.2.1 Plasmid pTA1392 construction for co-expression 
Using E. coli as the heterologous expression system for lanthipeptides has proved invaluable in 
the study of this RiPP family. From expression of enzymes for in vitro studies76,77 to in vivo 
reconstitution of a complete lanthipeptide biosynthetic pathway in a single vector2 , E. coli has 
been extensively used. The co-expression of an enzyme and its substrate in a single vector is a 
very elegant way of studying protein activity. Archaeal genetics tools and expression systems have 
lagged behind compared to bacteria and eukaryotes. Nevertheless, it is available today the highly 
engineered H. volcanii H1424 strain and the corresponding pTA1392 plasmid designed for 
inducible protein expression. As above-mentioned, this vector has a single multiple cloning site 
with a single promoter. Mimicking the pRSFDuet-1 design, an attempt was made to produce 
pTA1392 plasmids containing medA and medM genes under the control of two tryptophan 
promoters, respectively. These plasmids were constructed in a two-step fashion (Figure 18). 
Firstly, the genes of interest (all medA and medM genes) were individually inserted in the MCS of 
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Figure 18 Schematics of plasmid construction approach used for co-expression of medA and medM genes in 
Haloferax volcanii. a) vector pTA1392 with medA gene , b) vector pTA1392 with medM gene, *) sequence of the 
promoter and the medA gene fused to the His6-Tag, c) final construct containing both genes associated with their 
p.tnaA promoters. 
 
pTA1392. The genes for the putative precursor peptides were cloned by allowing for the 
expression of a His6-tag on their N-terminus. The medM genes were cloned in order to contain no 
tags. In the second step, the plasmids containing medA genes were used to amplify the region 
containing the p.tnaA promoter and the His6-tag fused medA. This fragment was further cloned in 
the downstream region of medM genes already cloned in pTA1392. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.4.2.2 Haloferax volcanii H1424 protein expression results 
The design of the pTA1392 for co-expression introduced some modifications to the vector. 
Therefore, to assure that the system was working before these modifications were introduced, we 
first expressed and purified only His6-tagged MedA peptides from H. volcanii containing pTA1392 
with medA genes (Figure 19). The expected average molecular masses for His6-MedA1, His6-
MedA2 and His6-MedA3 were 6470.987 Da, 8731.93 Da and 7960.749 Da, respectively. These 
masses were calculated based on the fact that the first Met of the peptide is removed after 
1st Step 2nd Step 
 
* 
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Figure 20 Mass spectra of Haloferax volcanii expression products after IMAC purification and ZipTip desalting. A) 
Haloferax volcanii transformed with plasmid containing the chromosomal medA1; B) Haloferax volcanii transformed 
with plasmid containing medA2; C) Haloferax voltanii transformed with plasmid containing medA3. 
 
ribosomal synthesis. This was because the initiator Met is removed in approximately two-thirds of 
the haloarchaeal proteins78. The IMAC eluted peptides samples were analyzed directly (after ziptip 
desalting) and after SPE by MS. Unfortunately, it was not possible to detect masses within the 
expected molecular weights (Figure 20). This also applies if we do not consider the N-terminal 
removal of Met. 
 
 
Figure 19 Sequence of the His6-tagged precursor peptides for H. volcanii co-expression. Colored in red are the serine 
and threonine residues essential for the dehydration reaction. 
 
The immediate conclusion is that either the protein expression or the protein purification 
protocols must be optimized. His6-tagged LanA peptides are typically overexpressed insolubly in 
the E. coli model68. The use of the strong denaturant agent guanidine hydrochloride became 
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therefore standard practice in purification protocols of lanthipeptides produced in E. coli. This 
agent could be included in further refinement and optimization of peptide purification procedures 
produced in H. volcanii, which will be essential for future studies of archaeal lanthipeptides.  
Other hypothesis is that production of MedAs is achieved but the linear peptides are cleaved by a 
non-specific H. volcanii peptidase. Given that no obvious peptidase is encoded in the 
H. mediterranei ATCC 33500 clusters, leader peptide removal could be performed by a protease 
that is elsewhere in its genome. This is observed in the biosynthesis of Class III and IV 
lanthipeptides, where the leader sequences are cleaved off, after peptide modification, by an 
unknown peptidase that is not encoded in the cluster. The result of this proteolysis are mature 
peptides of varying lengths29. H. mediterranei and H. volcanii chromosomal genomes share high 
homology64. Consequently, H. volcanii can encode a protease that targets the leader sequences of 
MedA peptides, even if it does not have lanthipeptide clusters. Under such circumstances, it 
would be only possible to purify the leader peptides of His6-MedAs.  
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4. Final Remarks  
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The natural world is still the major source of novel and exciting molecules. The use of 
bioinformatics tools in this genomic era will certainly continue to prove extremely useful in 
discovering this natural wonders of ribossomally synthesized and post transnationally modified 
peptides. 
Lanthipeptides, which were first thought to have mainly antibiotic activity are now endowed with 
a wider spectrum of bioactivities. Continuous efforts in genome mining will certainly uncover 
more. With this work, we aimed at identifying and characterizing, for the first time, lanthipeptides 
and the corresponding lanthipeptide modifying enzymes, LanMs, from the Domain Archaea. 
These LanM enzymes showed high homology to those present in the Bacteria and contain all the 
residues essential for enzyme function. Comparison of the putative precursor lanthipeptides 
encoded in different archaeal organisms revealed the conservation of promising, characteristic 
motifs and residues that might be essential for peptide-enzyme interactions. Analysis of the 
clusters with Bagel revealed little similarity with classical class II clusters lacking, for instance, the 
SunT-type LanT genes coding for bi-functional transporter proteins. These proteins are 
responsible for the final stages of lanthipeptide maturation, consisting on their cleavage and 
excretion from the cell. Transcription regulation genes were also lacking in most of the clusters. 
However, the presence of ABC transporters was common and can be associated either with 
export or self-immunity. Self-immunity will be relevant only if these lanthipeptides are 
archaeocins. 
Focusing on H. mediterranei ATCC 33500, it was found that the chromosomal cluster is most 
probably composed by lanA, lanM and also by a gene encoding a protein of unknown function. 
Regarding the plasmid cluster, it should contain medM2, medA2, medA3 and medM3 genes 
together with genes encoding an ABC transporter and a gene encoding a protein of unknown 
function. However, the confirmation of lanthipeptide presence will be required before function of 
the unknown proteins can be further investigated.   
The putative lanthipeptides explored in this study do not share homology with classical class II 
peptides. New peptides possibly encode novel bioactivity. If Archaea lanthipeptides have 
archaeocin activity, they would prove a valuable tool, for instance, in the development of 
Archaeal genetics tool-box. Archaeal genetic systems have always lagged behind the more 
sophisticated and extensively used bacterial and eukaryotic ones like those of E. coli or 
Saccharomyces cerevisiae. This was in part due to the lack of ready to use selective markers and 
their resistance genes. Most of the bacterial antibiotics that are readily available for the 
development of bacterial genetic manipulation systems, are not usable in archaeal systems. 
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Therefore, in archaea, the selection is mainly based on auxotrophic strains.  If the archaeal 
lanthipeptides identified in this study proved to have archaeocin activity and a self-immunity 
system (conferred by ABC transporters), they could be used in archaea to substitute the need for 
auxotrophic strains. This would obviously imply the need for bioactivity assays after archaeal 
lanthipeptide identification and characterization. 
Not only are the lanthipeptides interesting, as are the biosynthetic enzymes responsible for their 
post-translational modifications. Control over stereoisomery is one of the greatest challenges on a 
chemistry laboratory. The characteristic spatial conformations of class II peptides is mainly 
managed by LanMs. Substrate promiscuity was also confirmed in some enzymes. The possibility of 
producing chimeras consisting of the leader peptide sequence recognizable by an enzyme capable 
of a specific conformational modification of interest and a core peptide of our choice that can 
then be subjected to these new LanM catalyzed modifications, has an enormous potential for 
biotechnological applications. Recently, a protocol for a H. volcanii expression system in industrial 
settings was developed to tackle the environmental limitations of the preferred models for 
biotechnological applications, like the E. coli model. The fact that these enzymes evolved to 
function in high salinity and temperature environments, typical conditions of these industrial 
bioreactors, makes it sound to assume these archaeal lanthipeptide modifying enzymes extremely 
interesting for those same biotechnological applications at an industrial scale. 
The discovery of novel natural products is largely based on trial and error, where the need for 
improved tools is constant. With this work we constructed a vector that can be used for co-
expression of medA and medM genes in Archaea. This protocol could have tremendous 
applications for future studies in archaeal biosynthetic machinery and novel lanthipeptide 
discovery. Unfortunately, we were unable to establish the proof of concept that MedM enzymes 
do modify MedA peptides. In a near future, the protocols necessary for their co-expression and 
purification will be optimized in order to confirm that Haloferax mediterranei ATCC 33500 is a 
lanthipeptide producer. After this, the concept will have the potential to be applied to other 
archaeal lanthipeptides or RiPPs in general.  
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Appendix 1. Remainder of clusters identified through Bagel not used for comparison 
 
 
Figure 21 Putative lanthipeptide clusters identified through Bagel. In blue are the genes encoding the modifying 
enzymes LanM and in red the ABC transporter related gene. In green are the putative peptides identified by the 
software. Curiously, in the Halopiger djelfimassiliensis cluster the software identifies the domain DUF4135 ( LanM 
dehydration domain) and the LanC domains as separate proteins. Homology between Natrinema gari JCM 14663 and 
Natrinema sp. J7-2 might indicate that we are in the presence of the same organism. 
  
DUF4135 
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Appendix 2. Genes present in chromosomal and plasmid clusters of Haloferax 
mediterranei ATCC 33500 
Table 7 Genes present in chromosomal and plasmid clusters of Haloferax mediterranei ATCC 33500 
Chromossome cluster 
HFX_RS04215 acetate--CoA ligase 
HFX_RS04205 hypothetical protein 
HFX_RS04200 methylmalonyl-CoA mutase 
HFX_RS04195 Copper binding protein 
HFX_RS04190 ABC transporter ATP-binding protein 
HFX_RS04185 ABC transporter (transmembrane domain) 
Plasmid cluster 
HFX_RS15975 TetR/AcrR family transcriptional regulator 
HFX_RS15980 MFS transporter 
HFX_RS15985 hypothetical protein 
HFX_RS15995 oleate hydratase 
HFX_RS16010 ABC transporter 
HFX_RS16015 ABC transporter ATP-binding protein 
HFX_RS16020 hypothetical protein 
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Appendix 3. Predicted masses for His6-tagged LanA peptides for E. coli co-expression 
study 
Table 8 Predicted masses for His6-tagged LanA peptides for E. coli co-expression study. Each serine or threonine residue 
belonging to the core sequence can be subject to a dehydration reaction. Given that we have no means of ascertaining 
were leader sequence ends and core sequence begins an overestimation of the number of reactions is needed. For the 
loss of each water molecule, a shift of ~18Da is expected. 
His6-tagged LanA peptide Number of dehydrations Molecular mass in Da 
RSFMedA1 
No dehydration 6812,18 
1 dehydration 6794,18 
2 dehydrations 6776,18 
3 dehydrations 6758,18 
4 dehydrations 6740,18 
5 dehydrations 6722,18 
6 dehydrations 6704,18 
7 dehydrations 6686,18 
8 dehydrations 6668,18 
RSFMedA2 
No dehydration 9067,46 
1 dehydration 9067,46 
2 dehydrations 9067,46 
3 dehydrations 9067,46 
4 dehydrations 9067,46 
5 dehydrations 9067,46 
6 dehydrations 9067,46 
RSFMedA3 
No dehydration 8296,57 
1 dehydration 8278,57 
2 dehydrations 8260,57 
3 dehydrations 8242,57 
4 dehydrations 8224,57 
5 dehydrations 8206,57 
6 dehydrations 8188,57 
7 dehydrations 8170,57 
8 dehydrations 8152,57 
9 dehydrations 8134,57 
10 dehydrations 8116,57 
11 dehydrations 8098,57 
12 dehydrations 8080,57 
13 dehydrations 8062,57 
 
